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ABSTRACT OF THE DISSERTATION
INTERACTIONS BETWEEN ENDOTHELIN RECEPTOR B AND
TRANSCRIPTION FACTORS SOX10 AND PAX3 IN THE MELANOCYTE
LINEAGE
by
Marcia K. Lowenstein
Florida International University, 2009
Miami, Florida
Professor Lidia Kos, Major Professor
Genetic interactions that underlie developmental processes such as cell
differentiation and pattern formation are complex and difficult to elucidate.
Neural Crest (NC) cells and their derivatives offer an optimal system in which to
probe for these complex interactions as they acquire different cell fates and
constitute a variety of structures. The transcription factors Sox10 and Pax3 as
well as the transmembrane receptor Endothelin receptor b (Ednrb) are
temporally and spatially co-expressed early in NC cells and mutations in these
genes lead to similar hypopigmentation phenotypes due to a reduced number
of NC-derived melanocyte precursors, the melanoblasts. The goal of this study
was to establish whether Sox10 and Ednrb or Pax3 and Ednrb interact to
promote normal murine melanocyte development. Crosses of Sox10 or Pax3
with Ednrb heterozygous mutants showed that the double heterozygous
hypopigmentation

phenotype

was
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significantly

more

pronounced

than

phenotypes of single heterozygotes, implying that a synergistic interaction
exists between Sox10 and Ednrb and Pax3 and Ednrb.
This interaction was further explored by the attempt to rescue the Sox10
and Pax3 hypopigmentation phenotypes by the transgenic addition of Ednrb to
melanoblasts. Pigmentation was completely restored in the Sox10 and partially
restored in the Pax3 mutant mice. The comparison of the number of
melanoblasts in transgenic and non-transgenic Sox10 mutant embryos showed
that the transgenic rescue occurred as early as E11.5, a critical time for
melanoblast population expansion. Cell survival assays indicated that the
rescue was not due to an effect of the transgene on melanoblast survival.
A novel phenotype arose when studying the interaction between Ednrb and
Pax3. Newborns appeared normal but by 3.5 weeks of age, the affected pups
were smaller than normal littermates and developed a dome-shaped head;
some also developed thoracic kyphosis. Affected pups were dead by 4 weeks
of age: 80% were Pax3Sp/+ and 75% were female. When compared to normal
littermates, affected mice had brains with enlarged 4th ventricles and more glia
while skeletal staining showed kyphosis, wider rib cages and pelvic differences.
An epistatic interaction resulting from the mixing of genetic backgrounds that is
exacerbated in the presence of Pax3 heterozygosity is suspected.
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Chapter I.
INTRODUCTION
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I. INTRODUCTION
From fertilization to birth, cells undergo a series of changes that results in
the transformation of nonspecific cells into a complex living organism that has
all the necessary structures in the correct location time and time again. The
transformation of cells that look identical into specialized cells with specific
functions is the developmental process known as differentiation. As cells
differentiate they must also receive signals that dictate the structure into which
they will be incorporated; for instance keratinocytes, melanocytes, and
fibroblasts need spatial and temporal orientation to become functional skin.
These questions of differentiation and pattern formation can be elucidated by
studying the genetic networks that control these processes. In vertebrates, the
neural crest has served as a good model to study these questions.
1. Neural Crest
The neural crest (NC) is an ideal cell type in which to study cell fate and
specification. Unique to vertebrates, NC cells arise in the developing neural
tube and migrate to the far reaches of the developing organism, all the while
differentiating in accordance to environmental signals they encounter along the
way. Arising from the epithelium and undergoing mesenchymal transition
(Duband et al., 1995), NC cells emigrate from the dorsal aspect of the neural
tube. Depending on their migratory path these multipotent progenitor cells
differentiate into a variety of cells (Figure 1), including melanocytes, Schwann
cells, satellite cells, enteric glia, neurons and facial cartilage and bones
(Anderson, 1989; LeDouarin and Kalcheim, 1999). The diversity of structures
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arising from the NC has long intrigued developmental biologists; the central
question being, how does a group of cells that appears homogeneous give rise
to such diverse structures within the organism (Dupin et al., 2001; Gammill and
Bronner-Fraser, 2003; Shah et al., 1994)?
Development of the NC by protochordate ancestors is considered a major
evolutionary event in vertebrates and thus appears to be conserved in species
ranging from zebrafish to humans (Gammill and Bronner-Fraser, 2003; Gans
and Northcutt, 1983), enabling us to study NC cells and their gene networks
across species. Specifically the generation of NC cells begins as the ectoderm
separates into the neural ectoderm (also known as the neural plate which gives
rise to the central nervous system) and the non-neural ectoderm (which will
give rise to the epidermis); the border between these two areas will give rise to
NC cells (Gammill and Bronner-Fraser, 2003). As neurulation proceeds, a
subset of these border cells will begin their emigration (Selleck and BronnerFraser, 1995; Serbedzija et al., 1994) and subsequently populate the entire
length of the embryo. This process is exhaustive and once NC cells emerge
and migrate, this border known as the neural crest ceases to exist.
Early NC markers include Snail (for mice and fish; Slug for birds) (Locascio
et al., 2002), Foxd3 (Kos et al., 2001) and Group E Sox family members Sox9
(Mori-Akiyama et al., 2003) and Sox10 (Southard-Smith et al., 1998). Snail/Slug
have been shown in cultured cells to be important for the epithelialmesenchymal transition (Cano et al., 2000) and in vivo for the proper
specification (Aybar et al., 2003; LaBonne and Bronner-Fraser, 2000) and
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migration (LaBonne and Bronner-Fraser, 2000; Nieto et al., 1994) of NC
progenitor cells. Foxd3 is essential for proper differentiation of NC cells and
appears to act in concert with Snail/Slug on downstream targets necessary for
neural crest determination (Sasai et al., 2001).
Neural crest cells respond to both cell autonomous and external signals
based on spatiotemporal and developmental sensitivities (Le Douarin et al.,
2004; Paratore et al., 2002b; Shah and Anderson, 1997). Often referred to as
neural crest stem cells (NCSCs), many lineages appear to maintain a stem-like
quality throughout life (Dupin et al., 2000; Kim et al., 2003). Stem cells are
defined as those cells that remain undifferentiated and multipotent throughout
their lives, and generate progeny that can either remain multipotent or have a
bias towards terminal differentiation depending on external cues. While
embryonic stem cells remain totipotent, many other types of stem cells are
partially committed, probably due to the niche they inhabit; in turn, NCSCs give
rise only to neural crest derivatives (Le Douarin et al., 2004; Morrison et al.,
1997; Sommer, 2001).
In addition to the effects of intrinsic and extrinsic signals, terminal
differentiation into specific tissues and structures also depends on the axial
level from which the NC cells originate (Figure 2). Cranial NC cells migrate into
the branchial arches and the face to form bones and cartilage of the face and
neck, cranial nerves and some pigment cells. The vagal and sacral NC cells
migrate from different regions in the embryo but both are instrumental in
innervating the gastrointestinal tract of vertebrates. The cardiac NC contributes
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to, among other things, the musculoconnective tissue of large arteries of the
heart and the septum that permits separation of the aorta and pulmonary artery
(Le Douarin, 1982; Le Lievre and Le Douarin, 1975). Avian trunk NC cells
migrate in two waves, the first wave migrating ventromedially and ultimately
forming the sympathetic nervous system, glia of the peripheral nervous system
(PNS) and the dorsal root ganglia while the second wave migrates
dorsolaterally and is comprised of melanocyte precursors known as
melanoblasts (Henion and Weston, 1997; Le Douarin and Teillet, 1974). Murine
trunk NC cells also migrate in a temporally specified manner but vary from
avian NC migration in that murine NC cells are seen in the dorsolateral pathway
throughout the migratory period and it is those cells that will travel via the
ventromedial and ventrolateral pathways that are temporally different
(Serbedzija et al., 1994; Serbedzija et al., 1990). As with the avian NC, all NC
cells that migrate via the dorsolateral pathway will become melanocytes while
cells migrating via ventromedial and ventrolateral pathways will become glia of
the PNS and the dorsal root ganglia as well as several other derivatives
(LeDouarin and Kalcheim, 1999). The spatial-temporal pattern of NC cell
migration may be indicative of some level of predetermination of cell lineage or
may help restrict developmental potential as a consequence of timing and
migratory path.
2. Melanocyte Development
The journey from NC cell to a fully mature pigmented melanocyte begins
with the induction of the neural tube and the emergence of the NC. Cell lineage
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experiments show that at approximately E8.5, the first wave of murine NC cells
begin their emigration through the dorsolateral and ventromedial pathways;
migration down the ventrolateral pathway begins shortly afterwards (Serbedzija
et al., 1994). By E11.5, melanoblasts have populated all regions of the murine
embryo (Figure 3); as the embryo continues to develop, the melanoblasts cross
the basement membrane that divides the dermis from the epidermis and most
murine melanoblasts will subsequently take up residence in the hair follicle by
E16.5 while the others remain in contact with the basement membrane on the
epidermal side (Mayer, 1973). Once in the hair follicle, some melanoblasts will
settle into a stem cell niche and remain there undifferentiated until the proper
signaling pathway stimulates differentiation (Ohlstein et al., 2004). Other cells
will continue differentiating and will begin the process of producing melanin
shortly after birth. In addition to populating the hair follicle and the epidermis,
melanocytes also provide pigment cells to the stria vascularis of the inner ear,
the choroid of the eye, the Harderian gland and the atrioventricular valves of
the heart (Brito and Kos, 2008; LeDouarin and Kalcheim, 1999).
3. Pigmentation Mutants
Mouse pigmentation mutants have been a source of fascination and interest
to people over the ages. In fact, ancient Chinese documents reference mouse
pigmentation mutants that include albino and yellow mice. In the 1700s, mice
were popular pets in Europe, China and Japan due to the ease of care and
their many variations of coat color. Once Mendel’s laws of inheritance were
rediscovered in the early 1900’s, it was quickly recognized that mice provided a
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situation similar to that of the peas – that genetics could be studied using coat
color variation in mice. In this case however the model organism is a mammal
and shares 95% genome homology with humans. In addition, the mouse
genome has been extensively characterized and is easily manipulated thereby
making the mouse an excellent candidate in which to study genetic interactions
and disease (Jackson Laboratory, 2009; National Human Genome Research
Institute, 2002).
Given that the NC is so important that it has been deemed the 4th germ
layer, melanocyte development – or the lack of – has afforded the opportunity
to study the dynamics and specifics of NC specification and differentiation using
pigmentation models to track NC cell development. Spontaneous pigmentation
mutants such as Piebald lethal, Dom and Splotch have proven to be valuable
models

for

understanding

gene

regulatory

networks

involved

in

the

development of NC cells.
The piebald lethal mutation (EdnrbS-l) spontaneously arose at Jackson
Laboratory in April of 1959 in a second generation cross between a C3H/HeJ
female mouse with a head blaze and a bellyspot and a wildtype C57BL/6J
male. Almost immediately, it was recognized that this mutation was a recessive
allele as most pups were born black with white belly spots while several in each
litter were born white with black eyes and a black spot or two around the ears
and occasionally a black spot at the base of the tail. In addition to the difference
in coat color, the white pups typically died within the neonatal period of a
deficiency of myenteric ganglion cells (a decrease in the innervation of the
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lower intestinal tract). The mutant named lethal spotting also exhibited a
hypopigmentation phenotype, although less severe than piebald lethal, and the
same gastrointestinal lethality (Lane, 1966). Of interest is that the pigment cells
(melanocytes) and the enteric neurons, which are responsible for proper
innervation of the gastrointestinal tract, are both derived from NC cells (Le
Douarin and Kalcheim, 1999).
The gene affected in piebald lethal mice encodes Endothelin receptor b
(Ednrb), a G-coupled seven transmembrane receptor (Hosoda et al., 1994),
whose human homolog, EDNRB, is mutated in approximately 5% of cases of
Hirschsprung disease (Chakravarti, 1996; Puffenberger et al., 1994). The Ednrb
mutation has also been identified at the spotting lethal locus in the rat
(Ceccherini et al., 1995; Gariepy et al., 1996; Shin et al., 1997) and in horses
with the lethal white foal syndrome (Santschi et al., 1998).
The murine lethal spotting locus (Edn3ls) encodes the Ednrb ligand,
Endothelin 3 (Edn3) (Baynash et al., 1994). Endothelin 3 is a member of a
group of three related peptides, Edn1, Edn2 and Edn3, each encoded by a
separate gene. The peptides are produced as inactive preproendothelins that
undergo successive proteolytic cleavages to generate the 22 amino acid active
endothelins.
The developmental expression patterns of Ednrb and Edn3 have been
analyzed in avian and murine embryos. These studies showed that Edn3 is
expressed in the environment through which NC cells migrate while Ednrb is
expressed by the NC cells themselves (Hou et al., 2004; Nataf et al., 1998;
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Nataf et al., 1996). Avian cells giving rise to melanocytes, however, express not
Ednrb but a closely related receptor, Ednrb2 (Lecoin et al., 1998; Stone et al.,
1997).
In mice homozygous for Ednrb, there is a drastic reduction in the number of
melanocyte precursors from the time they can be detected by the expression of
the DOPAchrome tautomerase marker (Dct, also referred to as tyrosinase
related protein-2, Trp2). DOPAchrome tautomerase is first detected at E10.5 as
melanocyte precursors have already undertaken the dorsolateral pathway. This
suggested that the expression of functional Ednrb is important for the proper
migration of melanocytes before or just before E10.5 (Pavan and Tilghman,
1994). Ednrb was then expressed at different stages of embryogenesis under
the control of the tetracycline inducible system and confirmed that Ednrb
expression is required from E10.5-12.5 (Shin et al., 1999). Broad expression of
Ednrb is seen throughout the developing embryo; the Ednrb/Edn3 signaling
pathway appears to be critically important at E10.5-12.5 for the migration of
melanoblasts and enteric neuron precursors (Lee et al., 2003; Shin et al.,
1999).
In vitro studies in the quail showed that Edn3 markedly increases the
proliferation of pluripotent NC cells and eventually stimulates dramatic
increases in the number of melanocytes (Lahav et al., 1996; Stone et al., 1997).
In primary mouse NC cultures, Edn3 also increases the number of melanocyte
precursors (Reid et al., 1996). These observations are consistent with the
genetic data of Ednrb mutations and the previous demonstration that
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melanocyte precursors in vitro have binding sites for radio labeled Edn1, which
binds to Ednrb (as well as to a second murine Endothelin receptor – EdnrA)
(Reid et al., 1996).
In an attempt to rescue the mutant phenotype (spotting and enteric
aganglionosis) of the lethal spotting rat in which functional expression of Ednrb
is abolished, a transgenic rat expressing Ednrb under the control of the human
dopamine-β-hydroxylase (hDβH) promoter was created (Gariepy et al., 1998).
Rescue of the enteric aganglionosis phenotype was obtained in the progeny
resulting from the cross of the spotting lethal rat and the hDβH-Ednrb
transgenic rat. However, the pigmentation phenotype was not rescued. This
partial rescue can be attributed to the fact that in the rat, the hDβH promoter
directs expression only to a subset of central nervous system and PNS
precursor cells, not to melanocytes or their precursors. Expression is driven in
vagal NC cells (precursors of enteric neurons) from the stage at which they
begin to colonize the foregut but not during their migratory steps (Kapur et al.,
1991). The hDβH-Ednrb transgene’s ability to prevent enteric aganglionosis
shows that the critical time for the action of Ednrb during the development of
enteric neurons occurs after the divergence from the melanocytic lineage and
after they have reached the gut.
The Dominant megacolon (Sox10Dom) mutant also arose spontaneously in a
hybrid stock carrying bouncy (B6C3Fe a/a-bc) at N12 in 1979. Heterozygous
animals are characterized by variable white spotting and aganglionic
megacolon. Homozygous animals are embryonic lethal and die around E13.5
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depending on the genetic background. These phenotypes result from the
synthesis of a C-terminus truncated Sox10 (Sry-like high mobility box 10)
protein due to a point mutation that introduces a premature termination codon
in the Sox10 gene (Kuhlbrodt et al.,1998; Southard-Smith et al., 1998). Sox10
belongs to a class of transcription factors of the high mobility group (HMG)
showing HMG domain homology to the testis-determining factor SRY. It has
been proposed that the truncated Sox10 allele may exert its phenotypic effect
by acting in a dominant negative manner (Potterf et al., 2000).
Sox10 has been implicated in regulation of cell survival, proliferation and
cell specification (Schepers et al., 2002; Wegner, 1999). The heterozygous
mutation in humans results in neurocristopathies, the best known being
Waardenburg syndrome type II or type IV (Bondurand et al., 2007; Herbarth et
al., 1998; Paratore et al., 2002a; Pusch et al., 1998). A mouse mutant was
created in which LacZ was inserted into the Sox10 locus. The mutant displays
the same phenotype as SoxDom (Figure 5); apart from being important in the
development of melanocytes and enteric ganglia, Sox10 is also critical for the
proper differentiation of Schwann cells (Britsch et al., 2001) In addition, it has
been reported that Sox10 deficient mice lack an adrenal medulla as a result of
inappropriate specification of NC cells at the onset of migration and subsequent
cell death (Reiprich et al., 2008).
Sox proteins are found in all tissues and cells that have been analyzed thus
far, and not surprisingly, the individual Sox proteins have very precise speciesspecific patterns and locations (Carney et al., 2006; Hou et al., 2006; Wegner,
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1999). An additional feature of Sox proteins is that, depending on the cellular
context, they partner exclusively with other proteins in order to activate
downstream targets, as in the case of Sox10 and the transcription factor Pax3
for downstream activation of Mitf, a master melanocyte regulatory transcription
factor (Bondurand et al., 2000; Kuhlbrodt et al., 1998). In the case of Sox10 and
Pax3, activation of Mitf varies from 500-fold with Sox10 to 10-fold with Pax3 to
>1500-fold with Sox10 and Pax3 (Bondurand et al., 2000).
Cell survival, proliferation and specification are the first roles played by
Sox10 in the melanocyte lineage (Lee et al., 2000; Mollaaghababa and Pavan,
2003). Neural crest cells initially appear normal in the absence of Sox10 and
even begin migration; it is shortly after, in the post-migratory NC population that
abnormalities begin: cells become apoptotic and homozygous embryos start
dying shortly afterward (Kapur, 1999; Southard-Smith et al., 1998). During
specification of melanocytes, Sox10 has been shown to activate Mitf, and
together they activate DOPAchrome tautomerase (Dct). Dct functions in the
biosynthetic pathway of eumelanin (black pigment), initiating melanogenesis
(Ludwig et al., 2004; Tsukamoto et al., 1992).
Splotch (Pax3sp) is another spontaneous mouse mutant that displays a
spotting phenotype. Splotch is a point mutation within intron 3 of the paired
homeobox 3 (Pax3) gene that partners with Sox10. The mutation interferes with
normal splicing of intron 3 and results in 4 aberrantly spliced mRNAs with exon
4 deleted. The Pax3Sp mutation also disrupts the homodimerization of the
protein, a function associated with the octapeptide-encoding central segment of
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the gene (Epstein et al., 1993) that partners with Sox10. Pax3 is a member of
the paired class homeodomain family of transcription factors and first appears
in the murine embryo at E8.5 precisely at the dorsal part of the neural tube just
before closure (Goulding et al., 1991). It is subsequently found in the
developing brain, the dermomyotome of the developing somites, in the limb
buds and some craniofacial structures. Mice heterozygous for Pax3 mutations
display belly spotting, with occasional dorsal spotting on the back or tail. Pax3,
like Sox10, is essential for life and homozygous mutants fail to develop many
structures determined by the NC and are embryonic lethal by E13.5.
Homozygous embryos display limb abnormalities, exencephaly, heart defects,
open neural tube (spina bifida) and abnormal tail morphology. In humans,
heterozygous loss of function PAX3 mutations cause Waardenburg Syndrome I
and III (WSI,III). WSI phenotypes include abnormal placement of the inner
canthus of the eye resulting in a wide nasal bridge formation, skin
hypopigmentation, heterochromia iridis and deafness. WSIII phenotypes
include skeletal abnormalities and cardiopulmonary defects together with the
phenotypes observed in WSI.
Pax3 is crucial for survival of melanocyte progenitors until they reach the
migrating staging area (MSA; in chick) where they stay for 24 hours before
continuing their migration (Hornyak et al., 2001). Required for the expansion of
the progenitor population, one of the most interesting of Pax3’s functions is its
promotion of melanocyte development while simultaneously inhibiting terminal
differentiation. This is accomplished by Pax3 activating Mitf while competing
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with Mitf for binding sites on the Dct promoter (Corry and Underhill, 2005;
Hornyak et al., 2001; Lang et al., 2005).
4. Genes Governing Murine Melanocyte Development
The identification of the genes mutated in EdnrbS-l, Sox10Dom, Pax3Sp as
well as other spontaneous pigmentation mutants including Dominant white
(Kitw-v), Slaty (Dctslt), Silver (Pmel17si), Belted (Adamts20bt-2J) coupled to
genetics and developmental biology studies on insertional and targeted
mutants has allowed for the delineation of the molecular sequence of events
involved in the process of skin melanocyte development (Figure 6). Premigratory NC cells express transcription factors such as Snail/Slug, Sox10 and
Pax3 that do not impose a particular fate until certain signaling molecules
change the patterns of gene expression (Bondurand et al., 2000; Locascio et
al., 2002). It appears that the members of the Wnt family, Wnt1 and Wnt3, are
required for these cells to commit to the melanocytic lineage (Bronner-Fraser,
2004; Dunn et al., 2000; Hari et al., 2002). The Wnt pathway transcriptionally
regulates the expression of Mitf by the activation of β-catenin and Lef1 (Takeda
et al., 2000). At this point, those NC cells that left the neural tube and took the
dorsolateral pathway have undergone their first commitment step to becoming
a melanoblast. The Kitl/Kit pathway is required for the proliferation and survival
of these cells by activating Mitf at the protein level (Nishikawa et al., 1991;
Opdecamp et al., 1997; Yoshida et al., 1996). During this first commitment step,
Sox10 and Mitf cooperatively activate the expression of dopachrome
tautomerase (Dct) (Jiao et al., 2004; Ludwig et al., 2004; Potterf et al., 2000).
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Dct is a melanogenic enzyme and it is not clear why it is expressed at this early
stage since melanin is only produced at the end of the process of
differentiation, about six days later. Another specification marker expressed at
this time is the melanosomal protein Pmel17 (Baxter and Pavan, 2003). Kitl/Kit
signaling is no longer required, and the Edn3/Ednrb pathway takes over
controlling the expansion of the committed melanoblast population and, most
likely, allowing these cells to migrate further and reach the prospective skin
(Shin et al., 1999; Yoshida et al., 1996). Edn3/Ednrb signaling regulates the
expression of Mitf both at the transcriptional and translational level,
guaranteeing melanoblast survival and regulation of the melanogenic proteins
Dct, Trp1, and Pmel17 (Sato-Jin et al., 2008). While traveling along the dermis,
extracellular matrix proteins and metaloproteases such as Adamts20, are not
only required for their proper migration but also for their survival (Silver et al.,
2008). As melanoblasts cross the dermal/epidermal junction they undergo final
differentiation by expressing tyrosinase, the rate limiting enzyme for melanin
production.

While

Edn3/Ednrb

signaling

is

not

necessary

for

those

melanoblasts that have reached the epidermis, it is still capable of regulating
the expression of tyrosinase both transcriptionally and translationally (Sato-Jin
et al., 2008). In the epidermis, Kitl/Kit signaling becomes critical one more time
allowing for the survival of fully committed melanocytes (Yoshida et al., 1996).
Those melanocytes that reach the hair follicles remain, and some dedifferentiate to become the melanocyte stem cells that generate new transition
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cells at each hair cycle stage. No differentiated melanocytes remain in the
epidermis.
5. Genetic Backgrounds and Modifiers
Epistatic relationships between genes is a concept that dates back more
than half a century (Haldane, 1941). More recently, definitions describing this
concept have emerged with the majority opinion converging on the explanation
that a modifier is a gene that alters the expression of another gene, typically at
another loci (Futuyma, 1998; Suzuki et al., 2004). As the complexities of
genetic interactions come into focus, there is more and more interest from both
scientists and medical clinicians to investigate modifier genes: from the
standpoint of understanding underlying genetic networks to being able to treat
both monogenic and multigenic diseases that present with varying levels of
expressivity and penetrance in human patients. An example of a disease state
in which gene expression and penetrance of severity can vary between families
but also within families is Waardenburg Syndrome (WS). Waardenburg
syndrome is a neurocristopathy (disease of the NC) in which one of several
melanogenic genes are responsible for the majority of the cases in which the
genetics have been elucidated. Mutations in the genes SOX10, PAX3, MITF,
SNAI2, EDN3 and EDNRB have been identified in variant forms of WS and
associated with particular signs and symptoms which can include white
forelock, cochlear deafness, craniofacial anomalies, aganglionosis and skeletal
deformities of the upper limbs (Bondurand et al., 2007; Puffenberger et al.,
1994; Sanchez-Martin et al., 2002; Tassabehji et al., 1994; Tassabehji et al.,
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1992).

Fortuitously, mice carrying similar mutations of the aforementioned

genes are good models for the study of WS in humans (Tachibana et al., 2003).
Studying modifier genes in WS or other diseases turns out to be
complicated and results are difficult to interpret due to the multitude of unknown
factors that may potentially affect any aspect of gene expression. Not only is
the type of mutation important, but expressivity and penetrance may also be
influenced by the position of the mutation (i.e., which exon carries the mutation)
or whether the mutation is in a cis or trans position. In addition, mutations of the
same gene may have pleiotropic effects on phenotypic expression (Genin et al.,
2008; Goldfarb et al., 1992; Gouya et al., 2006).
One study that looked at epidermal growth factor receptor (EgfrtmlMag) during
embryonic development identified that the timing of the interaction was dictated
by the background in which the mouse was bred and that these background
strains significantly influenced the timing of homozygous lethality (Strunk et al.,
2004). Depending on the background, the critical time for epistatic influence on
the known genetic mutation varied in distinct windows of time: from E4.5-9.5,
E10.5-13.5 and E14.5-18.5. Over 15 different in-bred background strains were
analyzed but of particular interest to the current study were that embryos on a
C57BL/6J background died in mid-gestation while those embryos on a C3H
background died in late gestation. Strunk and colleagues (2004) concluded that
modifiers were present in all backgrounds yet function varied according to
varying temporal programs. And while the Egfr homozygous condition was
consistently embryonic lethal in all background strains, the study provided a
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view into the temporal window of epistatic connections and that what may
appear as stochastic in nature is not.
In another study, a mutation that interferes with cardiac formation actually
proceeded to different stages of development depending on the background
strain of the mouse (Astrof et al., 2007). Mice with the FN-null mutation
(absence of fibronectin) die very early during embryonic development; embryos
on the 129S4 background die of cardia bifida while those embryos on a
C57BL/6J background develop a central looped heart and die at a later
embryonic age. To identify novel gene candidates for modifiers of cardiac
development, F2 intercrosses between 129S4 and C57BL/6J strains were used
for genetic mapping and haplotype analysis. These analyses revealed a 1Mbp
interval on mouse chromosome 4 that contains a modifier of cardiogenesis in
FN-null mice. Microarray analysis on wildtype, heterozygous and homozygous
FN embryos identified 21 candidate genes, 5 of which had differential
expression between the two background strains.
Neural crest development appears to be influenced by modifiers in
background strains as well. As previously discussed, NC progenitors destined
for the enteric nervous system are modulated by the interaction between Sox10
and Ednrb; their mutations also appear to be modulated by modifiers present in
the C57BL/6J and C3H backgrounds. The C57BL/6J background aggravated
the aganglionosis phenotype and decreased hypopigmentation while the C3H
background produced the opposite effects. In fact, the effects on aganglionosis
penetrance were so significant that only 15% of pups on the C57BL/6J
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background survived compared to 78% of pups on the C3H background
(Cantrell et al., 2004).
Another set of intrasubspecific crosses of Ednrbs mice (Mayer Ednrbs
/Ednrbs and C3HeB/FeJ Ednrbs/Ednrbs) has identified mast cell growth factor
(MGF, now known as Kitl) as a modifier for the patterning of hypopigmentation
displayed by Ednrb mutants (Rhim et al., 2000) This study suggested that
alterations of Kitl expression in C3H mice may be responsible for the
appearance of white forelock hypopigmentation phenotype characteristic of
Waardenburg syndrome. Recent studies employing crosses between Ednrb
and Kit mutant as well as the transgenic addition of Edn3 to Kit mutants have
corroborated the existence of a synergistic interaction between the endothelin
and Kitl and signaling pathways in melanocyte development (Aoki et al., 2005;
Garcia et al., 2008)
A mutagenesis screen to expose modifiers responsible for the difference in
severity in Sox10 heterozygous WS identified 3 modifiers of Sox10, one of
which is on the GLI-Kruppel family member 3 (Gli3; a component of the
hedgehog signaling pathway) which exacerbates the pigmentation defect of
Sox10 heterozygosity (Matera et al., 2008). Finally, a detailed analysis of the
expression of various melanogenic genes and melanocyte viability on different
in-bred background strains revealed different numbers of melanoblasts among
the 8 parts of the embryo according to background strain (Loftus et al., 2009).
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6. Research questions
Investigations into whether Ednrb/Edn3, Sox10 and Pax3 interact
genetically sprung from their spatiotemporal patterns of expression in early
embryogenesis. Based on these patterns of co-expression and similarity of
phenotypes in mutants, it is likely that Sox10 and/or Pax3 interact with Ednrb
and possibly regulate its expression. Interactions between Sox10 and Ednrb
have been shown to modulate the development of enteric neurons (Cantrell et
al., 2004; Zhu et al., 2004), and an Ednrb enhancer that is activated specifically
in enteric neuron precursors has been identified that contains multiple binding
sites for Sox10 (Zhu et al., 2004). Recently, in human melanocytes, Sox10 has
been shown to directly regulate Ednrb at the transcriptional level through two
different promoters (Yokoyama et al., 2006). Given that Sox10 and Pax3
transactivate downstream targets in melanocyte development and that both
transcription factors are essential for survival and/or proliferation of melanocyte
progenitors, my research questions directly addressed whether or not these
transcription factors interact with Ednrb in the melanocyte lineage.
Question #1: Does Sox10 interact with Ednrb at the genetic level?
The analysis of the phenotype of Ednrb/Sox10 compound heterozygote
mouse mutants will allow us to establish whether Sox10 interacts with Ednrb in
an additive, diminishing or synergistic manner. Crosses between EdnrbS-l/+ and
Sox10LacZ/+ mice over 3 generations were examined and hypopigmentation of
resulting single mutants were compared to the hypopigmentation of double

20

mutants. An aggravated phenotype beyond the additive expectation will imply a
genetic interaction.
Question #2: Does Pax3 interact with Ednrb at the genetic level?
The analysis of the phenotype of Ednrb/Pax3 compound heterozygote
mouse mutants allowed us to establish whether Pax3 interacts with Ednrb in an
additive, diminishing or synergistic manner. Crosses between EdnrbS-l/+ and
Pax3Sp/+ mice over 3 generations were examined and hypopigmentation of
resulting single mutants compared to the hypopigmentation of double mutants.
An aggravated phenotype beyond the additive expectation will imply a genetic
interaction.
Question #3: Can the transgenic delivery of Ednrb to Sox10 haploinsufficient
melanocyte progenitor cells rescue the hypopigmentation phenotype of Sox10
mutant mice?
Sox10LacZ/+ mice were crossed with transgenic mice that express Ednrb
under the control of the Dct promoter (Ittah, Ph.D. dissertation, Florida
International Univ., 2006) and any differences in pigmentation between the
Sox10 heterozygote and the Sox10 heterozygote with the transgene were
evaluated. A normal coat color will imply that the additional Ednrb supplied
early on in development was sufficient to rescue the emerging melanoblasts
and restore coat color.
Question #4: Can the transgenic delivery of Ednrb to Pax3 haploinsufficient
melanocyte progenitor cells rescue the hypopigmentation phenotype?
Pax3Sp/+ mice were crossed with transgenic Dct-Ednrb mice to evaluate any
differences in pigmentation between the Sox10 heterozygote and the Sox10
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heterozygote with the transgene. A normal coat color will imply that the
additional Ednrb supplied early on in development was sufficient to rescue the
emerging melanoblasts and restore coat color.
Question #5: How early can the transgenic delivery of Ednrb to the Sox10
heterozygote mutant rescue its spotting phenotype?
Sox10LacZ/+ mice were crossed with the transgenic Dct-Ednrb mice. Thus,
Sox10 heterozygous mice carrying the transgene expressed additional levels of
Ednrb in their melanocyte precursors. Embryos from the cross Sox10LacZ/+ and
Dct-Ednrb were harvested at E11.5 and analyzed via in situ hybridization using
the Pmel17 riboprobe. If a qualitative difference emerges in the number of
melanocyte precursors between Sox10 heterozygotes with and without the
transgene, it will imply that the transgene is acting prior to E11.5 and is involved
in the expansion of the melanocyte precursor population.
Question #6: Does the transgenic delivery of Ednrb rescue melanoblasts in the
Sox10 heterozygote from an untimely death by apoptosis?
Sox10LacZ/+ mice were crossed with the transgenic Dct-Ednrb mice. Thus,
Sox10 heterozygous mice carrying the transgene expressed additional levels of
Ednrb in their melanocyte precursors. Embryos from the cross Sox10LacZ/+ and
Dct-Ednrb were harvested at E11.5 and E12.5 and analyzed using LacZ and
LysoTracker Red double staining to elucidate whether or not the melanoblasts
are dying at either E11.5 or E12.5. An increase in the number of double stained
cells traveling along the dorsolateral pathway will imply that there is a decrease
in the number of melanoblasts that make it to their final destination, resulting in
hypopigmentation.
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Question #7: What are the characteristics of the novel phenotype that arose
from the EdnrbS-l/+ cross with Pax3Sp/+?
A novel phenotype arose from crossing EdnrbS-l/+ with Pax3Sp/+. The most
obvious and striking characteristics were the development of hydrocephaly
during the 3rd and 4th weeks of life, 100% lethality and skeletal deformity. Gross
brain morphology was assessed with the aid of antibody staining to determine if
an increase in astrocytes (as a response to stress) was visible. In addition,
skeletal staining to describe skeletal differences between normal and mutant
littermates was attempted.
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Figure 1.1 Derivatives of neural crest cells (Alberts et al., 2002).
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Figure 1.2 Regions of the neural crest. Regions include the cranial NC, vagal
NC (near somites 1-7), cardiac NC (somites 1-3), trunk NC (about somite 6 to
the tail) and the sacral NC posterior to somite 28 (Gilbert, 2003).
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Figure 1.3 Neural crest cell migration. Neural crest cells delaminate from the
dorsal aspect of the neural tube. As migration progresses, Neural crest cells
traveling via the ventromedial pathway begin to take on the characteristics of
Schwann cell precursors (among other phenotypes). Neural crest cells that
migrate via the dorsolateral pathway exhibit melanocyte precursor traits. This
cartoon depicts the murine neural tube at E11.5. NT = neural tube; NC =
Notochord; DRG = dorsal root ganglia.

Figure 1.4 Sox10 mutant locus. Schematic representation of targeted deletion
of Sox10 locus and insertion of the reporter gene LacZ. The targeting vector
(top) via homologous recombination disrupted the Sox10 locus (middle)
inserting the LacZ gene (bottom) in its place (Britsch et al., 2001). Noncoding
exons are represented by black boxes while coding exons are represented by
white boxes. P = restriction site SpeI; N = restriction site NcoI.
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Figure 1.5 Pigmentation mutants. Typical hypopigmentation phenotypes of
mutant mice used in studies. The EdnrbS-l/+ hypopigmentation is quite small
while the Sox10LacZ/+ hypopigmentation (when present) and Pax3Sp/+
hypopigmentation (always present) are larger. Pigmentation defects in all three
genotypes are confined to the ventral aspect of the animals.
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Figure 1.6 Genes governing murine melanocyte development. A timeline of
melanogenic genes are detailed from the emergence of premigratory
melanoblasts (E8.5) through the differentiation of melanin producing cells
(E16.5). Transcription factors present as the neural tube closes at E8.5 are
essential for EMT, NC induction, specification of NC cells, survival and
migration. In addition, the Wnt/Frizzed signaling pathway is critically important
for proper cellular specification at this time. As NC cells emerge, Kitl/Kit
28

becomes important for the survival of melanoblasts and at E10.5, Dct, Pmel17,
Sox10 and Mitf are all important differentiation factors. Between E10.5-12.5, the
Edn3/Ednrb signaling pathway is necessary for proliferation and towards the
end of this time period Adamst20 is important for survival. Other necessary
differentiation factors that either turn on or remain activated in the next phase of
development (E12.5-16.5) are Trp1, Dct and Pmel17, along with the signaling
pathways Edn3/Ednrb and Kitl/Kit. At E16.5, tyrosinase is activated and along
with Trp1, Dct and Pmel17 the maturing melanocyte becomes a pigment
producing cell. Color key: transcription factors are in blue, signaling pathways
are green, enzymes in red, melanosomal protein in black, extracellular matrix
component in turquoise. EMT = epithelial mesenchymal transition, ep =
epidermis, hf= hair follicle, der = dermis, P1 = postnatal day 1, Kitl = Kit ligand,
Dct = DOPAchrome tautomerase, Edn3 = Endothelin 3, Ednrb = Endothelin
receptor b, Trp1 = Tyrosinase related protein 1, Mb = Melanoblast.
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II. INTERACTION BETWEEN THE TRANSCRIPTION FACTORS SOX10 AND
PAX3 WITH ENDOTHELIN RECEPTOR B IN THE MELANOCYTE LINEAGE
1. Abstract
Genetic interactions, the cornerstone of cell fate and specification, are
often difficult to elucidate due to the complex nature of cell development. Neural
crest (NC) cells arise in the developing neural tube and migrate throughout the
organism, all the while differentiating in accordance to environmental signals
they encounter along the way. The diverse array of NC derivatives, which
includes melanocytes, provides an intriguing system in which to explore the
complex interactions necessary for cell differentiation. Sox10, Pax3 and
Endothelin receptor b are temporally and spatially co-expressed early in NC
cells and mutations in these genes lead to similar hypopigmentation
phenotypes due to a reduced number of melanocyte precursors. The goal of
this study is to establish whether Sox10 and Ednrb and/or Pax3 and
Ednrb interact to promote normal murine melanocyte development.
Breeding experiments crossing heterozygous mutants of Sox10 and Ednrb or
Pax3 and Ednrb were set to determine if animals with mutations in both genes
exhibited an aggravated phenotype. Hypopigmentation was measured and
analyzed using Canvas 9, Matlab and Box-Cox transformations.

Double

heterozygous mutants display a phenotype that is significantly more
pronounced than phenotypes of single heterozygous animals implying that a
synergistic interaction exists between Sox10 and Ednrb and Pax3 and Ednrb.
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2. Introduction
In the mouse, emigration of NC cells from the neural tube begins around
embryonic day (E)8.5. Melanocyte precursors are few in number early in
development, despite the later need for numerous cells to populate the entire
skin (Mintz, 1967; Schaible, 1969). Mutations that decrease the number of
melanocyte progenitors early in embryogenesis cause significant alterations of
phenotype, resulting in areas of hypopigmentation. In fact, depending on the
timing and severity of the insult, the effects on hypopigmentation will vary since
melanocyte precursors proliferate along their migratory path. Melanocyte
progenitors emerge according to their axial level and the embryo is populated
from both the rostral and caudal ends with rostral melanoblasts emerging and
migrating slightly ahead of caudal melanoblasts; after melanoblasts have
populated the entire length of the embryo via the dorsolateral pathway they turn
inward to travel towards ventral aspects of the embryo (LeDouarin and
Kalcheim, 1999; Pavan and Tilghman, 1994). For this reason, many
hypopigmentation phenotypes present with ventral white areas, and depending
on the severity of the effect, dorsal spots and belts are seen. In the most
extreme cases, the animal is completely white.
The spatial and temporal specification, migration, proliferation and
differentiation

of

cells

depend

on

the

genetic

networks

controlling

developmental processes and phenotypes. It is this highly coordinated process
that generates cell diversity and proper morphology within each individual
regardless of species, and it is also what motivates developmental biologists

42

and geneticists to elucidate the transient stages between conception and
senescence.
Sox10 and Pax3 and Ednrb are present as the neural tube closes and NC
cells begin their emigration (Baynash et al., 1994; Goulding et al., 1991;
Wegner, 1999) and all appear to help orchestrate the NC cell journey towards
final determination. Sox10 is involved in the regulation of cell survival,
proliferation and cell specification (Mollaaghababa and Pavan, 2003; Schepers
et al., 2002) while Pax3 is crucial for the survival of melanocyte progenitors until
they reach the migratory staging area (MSA) and then later for proper migration
(Hornyak et al., 2001). Ednrb is not instructive in the initial specification of
melanocyte progenitors but is essential for survival, migration, proliferation and
later indirectly activating the downstream targets of melanin production (Hou et
al., 2004b; Lee et al., 2003).
Investigations into whether Ednrb, Sox10 and/or Pax3 interact genetically
sprung from their spatiotemporal patterns of expression in early embryogenesis
and that mutations of these genes can cause variations of Waardenburg
syndrome (Read and Newton, 1997; Tachibana, 1999).

Waardenburg

syndrome (WS) was originally clinically described as four different types, all
displaying pigmentary defects and some extent of hearing loss; the presence of
additional signs and symptoms determined further classification (Read and
Newton, 1997). Waardenburg syndrome Type I (WS I [MIM 193500]) were the
original cases described by the Dutch ophthalmologist and geneticist Petrus J.
Waardenburg back in 1947 in a meeting of the Dutch Ophthalmological Society
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(Waardenburg, 1951). The additional features included dystopia canithorum
and broad nasal root. Type III WS (WS III [MIM 148820]) is a more extreme
version of Type I and most patients with either type I or III are heterozygous for
Pax3 (Read and Newton, 1997; Tassabehji et al., 1992). Type II WS (WS II
[MIM 193510]) patients are profoundly deaf and have pigmentation defects;
mutations in Mitf are seen in 15% of the cases and there have been a couple of
cases with mutations in SNAI2 (Read and Newton, 1997; Tassabehji et al.,
1994), leaving approximately 85% of the cases from unknown mutations. Type
IV WS (WS IV [MIM 277580]) has the additional feature of Hirschprung’s
disease, the failure of the distal colon to be innervated by NC derived enteric
neurons which results in loss of peristalsis and inability to defecate (Shah et al.,
1981). Some Type IV patients have been diagnosed with mutations in Sox10,
Ednrb and/or Edn3 (McCallion and Chakravarti, 2001; Paratore et al., 2002;
Puffenberger et al., 1994).
Given the pattern of co-expression, similarity of phenotypes and the
presence of mutations in Sox10, Pax3 and Ednrb in the various forms of WS,
investigations into possible genetic interactions have begun. In fact, a
synergistic interaction between Sox10 and Pax3 has been identified in the
transcriptional regulation of Mitf (Bondurand et al., 2000) and Edn3 regulates
Mitf in an Ednrb-dependent manner (Sato-Jin et al., 2008) in the melanocyte
lineage. Typically, Sox10 mutations have been identified as nonsense or
frameshift mutations (Bondurand et al., 1999; Pingault et al., 1998; Touraine et
al., 2000) but recently long deletions at the Sox10 locus has been found to be
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the cause of deleterious effects, including the novel finding that Sox10 is
mutated in some cases of Type II WS (Antonellis et al., 2006; Bondurand et al.,
2007).
Taken together, I wanted to elucidate whether or not synergistic genetic
interactions exist among Sox10, Pax3 and Ednrb in the development of the
melanocyte lineage and generation of a normal coat color pattern. In order to
do so, specified matings were set to evaluate whether or not the phenotype of
double heterozygous animals (Sox10

LacZ/+

::EdnrbS-l/+

or Pax3Sp/+::EdnrbS-l/+)

was significantly exacerbated when compared to the phenotype of the single
heterozygous animals. Areas of hypopigmentation were quantified and
statistical analyses performed.
3. Materials and methods
3.1 Animals and Genotyping
Heterozygous Ednrbs-l on SSL/Le background and Pax3Sp on C57BL/6J
background were originally obtained from Jackson Laboratory and maintained
in the FIU Animal Care Facility. Heterozygous Ednrbs-l mice display small to
medium areas of ventral hypopigmentation while homozygous animals are
almost completely white, with small areas of pigmentation around the pinna and
base of the tail. Tail biopsies were used as sources of genomic DNA for PCR
genotyping (Appendix I.A). To detect the Ednrbs-l allele, the tightly linked
D14Mit7 microsatelite polimorphic marker (Metallinos et al., 1994) was used to
distinguish between Ednrbs-l and C57B/6J mice using conditions previously
described (Pavan and Tilghman, 1994; and Appendix I.B).
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Pax3Sp animals

carry a point mutation within intron 3 of the paired homeobox 3 (Pax3) gene on
mouse Chromosome 1. The mutation interferes with normal splicing of intron 3
and leads to at least 4 aberrantly spliced mRNAs with exon 4 deleted. Pax3Sp
heterozygotes consistently display ventral hypopigmentation; mice homozygous
for this mutation are embryonic lethal by E13.5. To genotype Pax3Sp mice, the
intron 3/exon 4 boundary of Pax3 was amplified with primers: P3in3F (5’GAGAGGGTTGAGTACGTTAGCTGG-3’)
CTCGCTCACTCAGGATGCC-3’).

Products

and
were

P3ex4
visualized

on

(5’a

15%

polyacrylamide gel resulting in a single band around 230bp for a wildtype and a
heteroduplex band at this same site for the heterozygote (Appendix I.B).The
PCRs were performed for 30 cycles under the following conditions: 94C for 30
s, 58C for 30 s, 72C for 30 s.
The generation of Sox10tmlWegLacZ (from here on noted as Sox10LacZ) mice
was described by Britsch et. al. (2001). Briefly, Sox10 was mutated using a
targeting vector that deleted the coding sequence and inserted LacZ into the
allele. We have maintained these mice by backcrossing and keeping them on
their original mixed C3H background. While many Sox10LacZ/+ mice have ventral
hypopigmentation, it is not a consistent phenotype thereby requiring
genotyping. Tail biopsies were used as sources of genomic DNA for PCR
genotyping

using

the

following

primers:

5’

Sox10

(5’-

CAGGTGGGCGTTGGGCTC-3’); 3’ Sox10 (5’-CAGAGCTTGCCTAGTGTCTT3’); and 3’ LacZ (5’-TAAAAATGCGCTCAGGTCAA-3’). The PCRs were
performed for 32 cycles under the following conditions: 94ºC for 30 s, 55ºC for
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30 s, and 72ºC for 30 s.

Products were visualized on a 2% agarose gel

resulting in a 500bp band for wildtype and a 600bp for the mutated allele
(Appendix I.B). Animals homozygous for Sox10 are embryonic lethal, typically
by E13.5.
All animals used in this study were housed in the Animal Care Facility at
Florida International University (Miami, FL). Water and murine chow were fed
ad libitum and light/dark was cycled every 12 hours. All animal work was
performed according to institutional guidelines established by NIH (Guide for
the Care and Use of Laboratory Animals, 2009; IACUC protocol # 08-001).
3.2 Crosses and Phenotype Analysis
Sox10LacZ/+ mice were crossed with Ednrbs-l/+ mice to produce offspring that
were either heterozygous for Sox10, Ednrb or double heterozygous for Sox10
and Ednrb. At 2 months of age hypopigmentation was measured and the area
calculated using the Canvas 9 program; double heterozygous animals were
euthanized at this time. First generation single heterozygous animals were
crossed and hypopigmentation of F2 offspring was evaluated at 2 months of
age as described. As with F1, F2 double heterozygous animals were euthanized
and single heterozygous animals were crossed to produce a third generation of
animals. Again, at 2 months of age hypopigmentation was measured and all F3
animals were euthanized.
Pax3Sp/+ mice were crossed with Ednrbs-l/+ mice as described above, also for
three generations, to produce progeny that were either Pax3Sp/+, Ednrbs-l/+ or
Pax3Sp/+ ::Ednrbs-l/+.
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3.3 Statistical Analysis
In order to evaluate the data, hypopigmentation areas of the single
heterozygous animals were added and then compared to the hypopigmentation
of animals manifesting both mutations. These data were then analyzed using a
one-tailed t-test, the Wilcoxon rank sum test and Box-Cox square root
transformations. These statistical tests are non-parametric, rely on independent
samples and do not assume normality of data. In addition, individual data points
were plotted on a scatter plot using Matlab (The MathWorks, Inc.).
4. Results
4.1 Genetic Interaction between Sox10 and Ednrb
To elucidate whether or not genetic interactions exist between Sox10 and
Ednrb in the melanocyte lineage, I analyzed the sum of hypopigmentation of
mice carrying heterozygous alleles in Sox10 and Ednrb and compared it to the
hypopigmentation of mice that were heterozygous for both genes (Figure 1).
Representative pictures of the three generations of mice imply some interaction
between Sox10 and Ednrb in generations 2 and 3. Ednrbs-l/+ mice typically have
proper pigmentation or a very small area of ventral hypopigmentation, whereas
null mutant (Ednrbs-l/s-l) mice are completely white with the occasional dark spot
near the pinna and/or at the base of the tail. Sox10LacZ/+ mice have ventral
hypopigmentation approximately three-quarters of the time (Sox10LacZ/LacZ mice
are embryonic lethal). A scatter plot of hypopigmentation areas of individual
animals (Figure 2) indicates that a genetic interaction becomes apparent in
generations 2 and 3 since the areas of ventral hypopigmentation look larger in
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the double heterozygous mice than the areas of hypopigmentation in single
heterozygous animals.
Hypopigmentation was measured by photographing mice at two months of
age and using the Canvas 9 program to outline and calculate the area. While
areas of hypopigmentation varied, the individual values were used in nonparametric assays that did not assume normality of data. Three statistical tests
were used to analyze the data: Box-Cox square root transformations, Wilcoxon
rank sum test and the one-tailed t-test, each of which took into account unequal
size of the groups and variability and standard error of the samples. All
analyses produced similar results (Tables 1 and 2).
In generation one (n=71), surprisingly, hypopigmentation of Sox10LacZ/+ was
larger than hypopigmentation seen in Ednrbs-l/+ or Sox10LacZ/+::Ednrbsl/+ mice.
However, in generations 2 (n=52) and 3 (n=27) the hypopigmentation of
Sox10LacZ/+-::Ednrbs-l/+ mice was significantly larger (means of 404 and 298; p
values ranging from .005-.012, and .005-.026, respectively for F2 and F3) than
the sum of the single heterozygous animals (means of 66.5 and 37.7,
respectively for F2 and F3; Table 3) implying that background exerts an
influence on pigmentation (Cantrell et al., 2004) and that as the C3H and
C57BL/6J backgrounds blend the nature of the interaction between Sox10LacZ/+
and
Ednrbs-l/+ becomes apparent.
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4.2 Genetic Interaction between Pax3 and Ednrb
As with the cross mentioned above, Pax3Sp and Ednrbs-l heterozygous mice
were crossed to reveal whether or not a genetic interaction exists between
these melanocytic genes (Hornyak et al., 2001; Pavan and Tilghman, 1994). All
animals were genotyped and progeny crossed as described above, and at 2
months of age, hypopigmentation was photographed and measured using the
Canvas 9 program. Representative pictures (Figure 3) of the three generations
of mice imply some interaction between Pax3 and Ednrb. As mentioned above,
Ednrbs-l/+ mice exhibit either proper pigmentation or a very small area of ventral
hypopigmentation while the Ednrbs-l/s-l mice are completely white with the
occasional dark spot near the pinna and/or at the base of the tail. Pax3Sp/+
mice, on the hand, consistently have ventral hypopigmentation and Pax3Sp/Sp
mice are embryonic lethal by E13.5.
A scatter plot of the hypopigmentation areas of individual animals (Figure 4)
indicates that a genetic interaction becomes apparent in generations 2 and 3.
The three statistical analyses (Tables 4 and 5), Box-Cox square root
transformations, Wilcoxon rank sum test and the one-tailed t-test, all indicate
that a significant difference exists between the area of hypopigmentation of the
double heterozygous mutants in generations 2 and 3 (means of 477.8 and
340.0; p values ranging from .010-.079 and .0004-.021, respectively for F2 and
F3) when compared to the sum of the areas of hypopigmentation of the single
heterozygous mutants (means of 12.5 and 84.0, respectively for F2 and F3;
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Table 6) even when considering the unequal sample sizes of the groups and
the natural variability between the animals.
5. Discussion
Manipulating pigmentation phenotypes has long been a model system in
which to elucidate genetic crosstalk and influences in health and disease. In the
case of Waardenburg Syndrome, four out of the five genes responsible for
variants of this disease are also involved in the development of melanocytes:
Sox10, Pax3, Ednrb and Mitf. Investigating genetic interactions in the context of
biological systems has the tremendous potential to increase our understanding
of cellular development and the etiology of disease. One way to do this is by
creating compound heterozygotes in animal models to investigate in vivo
genetic interactions. Recent examples that have employed this approach
include studies investigating candidate genes for autism spectrum disorder and
cardiac development.
PTEN (PI3K pathway) and SLC6A4 (serotonin pathway) are considered
autism candidate genes (Bartlett et al., 2005; Herman et al., 2007). Page and
colleagues (2009) examined the question of whether these two genes, both
candidates for a complicated disease and whose pathways intersect (Ji et al.,
2006) , interact by creating double heterozygous animals and evaluating their
phenotype. In a completely different system, the effect of using compound
heterozygous mice was employed to study genetic interactions between
Gata4/6 and Tbx5 in cardiac development. Gata4 and Gata6 belong to a (zinc
finger) transcription family, are expressed in a variety of cells and are important
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in cardiovascular development (Molkentin, 2000; Pu et al., 2004); Tbx5 is a
transcription factor whose haploinsufficiency causes a variety of cardiac defects
(Bruneau, 2008). Based on earlier experiments indicating a possible interaction
between Gata4 and Tbx5, heterozygous Gata4 or Gata6 mice were crossed
with Tbx5 heterozygous mice to generate compound heterozygous Gata4+/::Tbx5+/- or Gata6+/- ::Tbx5+/- embryos and pups in order to determine whether
or not synergistic interactions occur between these genes (Maitra et al., 2009).
Both of these studies helped elucidate interactions between genes of interest.
In this study, I have taken mice that were heterozygous for either of the
transcription factors Sox10 or Pax3 and crossed them with mice harboring the
heterozygous mutation of Ednrb. Progeny of the Sox10LacZ/+ and Ednrbs-l/+
cross, alongside progeny of the Pax3Sp/+ and Ednrbs-l/+ cross, were evaluated
over the course of three generations to see if there was a genetic interaction
between either transcription factor and Ednrb.
The Sox10LacZ/+ and Ednrbs-l/+ crossed over three generations produced
second and third generation double heterozygous progeny in which the area of
hypopigmentation was significantly larger than the sum of the area of
hypopigmentation of single heterozygous animals from the same generation. A
previous study using an Ednrb hypomorph (Ednrbs) crossed with a
spontaneously occurring Sox10 mutation (Sox10Dom/+) or the knock-in
Sox10LacZ/+ revealed that the pigmentation phenotype, in addition to the hearing
and aganglionosis phenotypes, seen in Ednrb and Sox10 haploinsufficient mice
were aggravated in the double heterozygous animals (Stanchina et al., 2006).
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In addition, pups born with a mutation in both Ednrb and Sox10Dom/+ had
increased mortality regardless of the Ednrb allele used in the cross (Cantrell et
al., 2004; Stanchina et al., 2006).

The Ednrb hypomorph (Ednrbs) used in

these studies retains about 25% of functional receptor activity; even without
losing all the functional capacity of the mutated allele, a genetic interaction was
seen between Ednrb and Sox10Dom/+. This study used the Ednrbs-l allele which
has essentially no receptor activity.
However, data from two other studies suggested no interaction between
Sox10 and Ednrb in the melanocyte lineage (Cantrell et al., 2004; Hakami et
al., 2006). The differences in the results found in these studies could be
attributed to the allelic variants of the mouse mutants that were used. Cantrell
et al (2004) and Hakami et al (2006) used the Sox10 variant Dom. Sox10Dom
mice lack the transactivation domain (Herbarth et al., 1998; Southard-Smith et
al., 1998) of the gene; Sox10LacZ mice (used by Stanchina et al and in this
study) have LacZ knocked into the gene at the initiation codon (Britsch et al.,
2001). Cantrell et al. (2004) used EdnrbtmlYwa in which 4.2kb is replaced by a
neomycin cassette in exon 3 rendering the gene null (Hosoda et al., 1994)
while Hakami et al. (2006) and Stanchina et al. (2006) used a Ednrbs
hypomorph where a 5.5kb retrotransposon was placed in intron 1 rendering the
gene 25% functional (Roix et al., 2001). Cantrell et al. (2004) and Hakami et al.
(2006) also used Ednrbs-l in which all coding exons are deleted and there is no
functional transcript available (Hosoda et al., 1994). This study consistently
used Sox10LacZ and Ednrbs-l mice to assess whether an interaction between
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these genes exists; neither heterozygous animal had residual functional effects
from the mutated allele.
Another difference between these studies that may have influenced the
varying outcomes is the background of the mouse strains used. Although the
mice originally came from the same sources (e.g. Jackson Labs; Dr. Wegner,
Universitat Erlangen), they had typically resided in the animal facilities of the
respective labs for some time. Some mice were outcrossed to switch the
background (Cantrell et al., 2004; Hakami et al., 2006) while other mice were
maintained in their mixed background for a number of years (Stanchina et al.,
2006). The Ednrbs-l mice used in this study were originally switched over from
an LLE background to a C57BL/6J background where they have been
maintained for years. The Sox10LacZ mice were originally on a C3H mixed
background and have been backcrossed since their arrival. Colony size and
number of years being inbred or outcrossed could increase, or decrease, the
expression of background modifiers and genetic heterogeneity which in turn
might affect gene expression and penetrance (Cantrell et al., 2004; Genin et al.,
2008; Strunk et al., 2004). Biological complexities of studying genetic
interactions in vivo imply that a myriad of genes, allelic variants of those genes,
modifiers and/or environmental influences can impact gene expression
underscoring the need to perform experiments over generations and in varying
backgrounds to truly elucidate genetic interactions. The C57BL/6J background
is known to diminish pigmentation phenotypes (Cantrell et al., 2004), which is
possibly why the hypopigmentation of generation 1 double heterozygous
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animals was not significantly different than the hypopigmentation of the single
heterozygous animals. As the single heterozygous animals from each
subsequent generation were crossed, the backgrounds continued to mix to
create a more homogeneous (mixture of C57BL/6J + C3H) background
allowing the phenotype from the genetic interaction to become apparent.
Given that Ednrb and Sox10 are spatially and temporally co-expressed as
neural crest cells emigrate from the dorsal aspect of the neural tube and
melanocyte and enteric neuron precursors migrate via the dorso-lateral and
ventro-medial pathways, respectively (Le Douarin and Dupin, 2003), one might
suspect that the expression of one might be dependent on the expression of
the other. In fact, interactions between Sox10 and Ednrb have been shown to
modulate the development of enteric neurons (Cantrell et al., 2004; Zhu et al.,
2004), and an Ednrb enhancer that is activated specifically in enteric neuron
precursors has been identified that contains multiple binding sites for Sox10
(Zhu et al., 2004). Recently, in human melanocytes, Sox10 has been shown to
directly regulate Ednrb at the transcriptional level through two different
promoters (Yokoyama et al., 2006).
In situ hybridization has shown that Sox10

Dom/Dom

embryos still express

Ednrb and that, at least for neural crest cells explants, the converse is true as
well, that Ednrb null mutant cells express Sox10 (Hakami et al., 2006).
However, the expression of either gene in the mutant of the other occurs in a
significantly reduced manner. Of interest is that in these mutants certain
structures (e.g., the PNS in Sox10 homozygous mice) or cells (e.g.,
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melanoblasts in Ednrb homozygous mice) begin to deteriorate or are missing.
Structures that are deteriorating or missing prevent the distinction between the
lack of expression of the gene of interest due to regulation of the mutated gene
or simply because the tissues and structures where the gene is expressed are
not there Ednrb and Sox10 may interact in a functional hierarchical manner at a
specified time during development to promote melanoblast differentiation. For
example, while Ednrb is not required for initial melanoblast specification, it is
required during E10.5-E12.5 for proper melanocyte development (Lee et al.,
2003; Shin et al., 1999). This is the same critical window in which Sox10
expression is needed for melanoblasts to proceed normally in development
(Britsch et al., 2001).
Sox proteins are abundant in tissues, each of them present in a variety of
tissues and transcriptionally active at different times throughout the vertebrate
lifecycle (Wegner, 1999). Besides being important architectural modifiers, Sox
proteins cooperatively bind with other proteins to ensure specificity of their
action (Kuhlbrodt et al., 1998; Schlierf et al., 2002). Sox10 undoubtedly needs
a partner to activate (Kamachi et al., 2000) and become fully functional in
melanoblast development and, since Sox10 and Pax3 work coordinately to
transcriptionally activate the melanocytic downstream target Mitf, could they
possibly each work to activate Ednrb as well?
Pax3Sp/+ mice have a phenotype similar to Ednrbs-l/+ and Sox10LacZ/+ (ventral
hypopigmentation), but unlike the other mutants Pax3Sp/+ is a fully penetrant
phenotype, apparent in all heterozygous mice. Pax3 is present in the dorsal
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aspect of the neural tube as NC cells begin their emigration and while the
prospective melanocytes are in the MSA prior to their emigration. Acting as a
nodal point in melanocyte stem cell differentiation, Pax3 in conjunction with
Sox10 coordinately regulates Mitf (Bondurand et al., 2000; Potterf et al., 2000)
and subsequently acts to repress this activation as well (Lang et al., 2005). In
NC derived enteric neurons, Sox10 and Pax3 synergistically interact to regulate
c-RET (Lang et al., 2000) Intriguingly, a Sox10 transgene put under the control
of the Pax3 promoter rescues Sox10 deficient melanocytes (Hou et al., 2004a).
Given the seemingly related roles that Sox10 and Pax3 play in melanogenesis,
the question of whether Pax3 and Ednrb interact needed to be addressed.
Heterozygous mutants of Pax3 and Ednrb were crossed to evaluate the
hypopigmentation of single and double heterozygous animals for 3 generations.
The results of these crosses indicate that there is indeed a genetic interaction
between Pax3 and Ednrb in the melanocyte lineage. As with the Sox10
experiment the progeny of Pax3Sp/+ crossed with Ednrbs-l/+ showed that the
hypopigmentation of the double mutants in generations 2 and 3 was
significantly larger than the sum of the hypopigmentation of the single mutants.
Haploinsufficiency of Sox10 or Pax3 in combination with haploinsufficiency
of Ednrb caused an aggravated hypopigmentation phenotype in second and
third generation progeny. First generation results may have been obscured by
initial mixing of varying genetic backgrounds (C3H, C57BL/6J and LLE) which
may have altered the expressivity and penetrance of the pigmentation
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phenotype. Taken together, these results suggest a genetic interaction between
Sox10 and Ednrb as well as Pax3 and Ednrb.
The question that naturally follows is whether the hypopigmentation
phenotype of these mutants could be rescued by the targeted addition of the
complimentary gene. For instance, could the Sox10/Pax3 phenotype be
rescued by additional Ednrb or could the Ednrb phenotype be rescued by
additional Sox10/Pax3? In light of previous research showing that Ednrb
contains multiple binding sites for Sox10 in enteric neurons (Zhu et al., 2004)
and in human melanocytes (Yokoyama et al., 2006), I will attempt to answer
this question by delivering additional Ednrb to Sox10s-l/+ and Pax3Sp/+ mice.
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Figure 2.1 Sox10 and Ednrb double heterozygosity results in an aggravated
hypopigmentation phenotype. Representative pictures of hypopigmentation for
each genotype show ventral hypopigmentation of double heterozygous mutants
for generation 1 was not different than the hypopigmentation of single mutants.
In generations 2 and 3, double heterozygous mice had larger areas of
hypopigmentation than did the Sox10 heterozygous and the Ednrb
heterozygous animals (F1 = 1st generation, F2 = 2nd generation, F3 = 3rd
generation).
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Figure 2.2 Double heterozygous progeny of generations 2 and 3 exhibit
larger areas of hypopigmentation than single heterozygous animals.
Numerical scatter plots of individual progeny of Sox10LacZ/+ crossed with
Ednrbs-l/+ over three generations, including means and standard deviations.
The numbers below the genotype represent the number of animals in that
group; white area in mm2 denotes area of hypopigmentation.
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Box-Cox square
root
transformation

Wilcoxon rank sum
test

One-tailed ttest

F1

NS

NS

NS

F2

p = .012

p = .005

p = .010

F3

p = .026

p = .014

p = .005

Table 2.1 Sox10 and Ednrb double heterozygosity results in an aggravated
phenotype. Various analyses were employed given that samples were uneven
in size. Statistical analyses robustly indicate that in generations 2 and 3 a
statistically significant difference exists between the sum of hypopigmentation
of single heterozygous animals (Sox10lacZ/+ and Ednrbs-l/+) and the hypopigmentation of double heterozygous animals (Sox10lacZ/+::Ednrbs-l/+; F1 = 1st
generation, F2 = 2nd generation, F3 = 3rd generation).
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Generation

Genotype
Ednrbs-l/+
Sox10LacZ/+
Ednrbs-l/+::
Sox10LacZ/+

F1

Ednrbs-l/+
Sox10LacZ/+
Ednrbs-l/+::
Sox10LacZ/+
Ednrbs-l/+
Sox10LacZ/+
Ednrbs-l/+::
Sox10LacZ/+

F2

F3

Number
Mean area of
of
hypopigmentation
animals
40
25
7
221
28
168

Significance

NS

17
17
18

15
118
404

p=.005

11
8
8

6
82
298

p=.014

Table 2.2 Wilcoxon rank sum test of hypopigmentation in Sox10 and Ednrb
single heterozygotes versus double heterozygosity. In F2 and F3 progeny,
hypopig-mentation is significantly larger in Ednrbs-l/+::Sox10LacZ/+ mice than in
mice with either gene mutated alone (NS = not significant, F1 = 1st generation,
F2 = 2nd generation, F3 = 3rd generation).

Average of
Hypopigmentation of
Single Heterozygous

Average of
Hypopigmentation of
Double Heterozygous

F1

53.6

168.5

F2

66.5

404.0

F3

37.7

298.0

Sox10LacZ/+ x EdnrbS-l/+

Table 2.3 Sums of averages. The sum of hypopigmentation averages for single
heterozygous animals (Sox10LacZ/+ x EdnrbS-l/+) compared to the hypopigmentation average for double heterozygous siblings (Sox10LacZ/+::EdnrbS-l/+).
Levels of significance are listed by statistical measure used in Table 1. (F1 = 1st
generation, F2 = 2nd generation, F3 = 3rd generation).
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Figure 2.3 Pax3 and Ednrb double heterozygosity results in an aggravated
hypopigmentation phenotype. Representative pictures of hypopigmentation
for each genotype show ventral hypopigmentation of double heterozygous
mutants for generation 1 was not different than the hypopigmentation of
single mutants. In generations 2 and 3, double heterozygous mice had much
larger areas of hypopigmentation than did the Pax3 heterozygous and the
Ednrb heterozygous animals (F1 = 1st generation, F2 = 2nd generation, F3 = 3rd
generation).
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Figure 2.4 Double heterozygous progeny of generations 2 and 3 exhibit
larger areas of hypopigmentation than single heterozygous animals.
Numerical scatter plots of individual progeny of Pax3Sp/+ crossed with Ednrbsl/+
over three generations, including means and standard deviations. The
numbers below the genotype represent the number of animals in that group.

Box-Cox square root Wilcoxon rank sum
transformation
test

One-tailed t-test

F1

NS

NS

NS

F2

p = .079

p = .037

p = .010

F3
p = .021
p = .004
p = .0004
Table 2.4 Pax3 and Ednrb double heterozygosity results in an aggravated
phenotype. Various analyses were employed given that samples were
uneven in size. Statistical analyses robustly indicate that in generations 2 and
3 a statistically significant difference exists between the sum of
hypopigmentation of single heterozygous animals (Pax3Sp/+ and Ednrbs-l/+)
and the hypopig-mentation of double heterozygous animals (Pax3Sp/+::Ednrbsl/+
; F1 = 1st generation, F2 = 2nd generation, F3 = 3rd generation).
64

Generation
Genotype
F1

Ednrb+/Pax3+/Pax3+/-::
Ednrb+/-

F2

Ednrb+/Pax3+/Pax3+/::Ednrb+/-

F3

Ednrb+/Pax3+/Pax3+/::Ednrb+/-

Number
of
animals
54
8
50

Mean area of
hypopigmentation

Significance

3
327
349

NS

19
20
12

7
238
478

p=.037

21
23
18

10
152
340

p=.004

Table 2.5 Wilcoxon rank sum test of hypopigmentation in Pax3 and Ednrb
single heterozygous versus double heterozygosity. In F2 and F3 progeny,
hypopig-mentation is significantly larger in Ednrbs-l/+::Pax3Sp/+ mice than in
mice with either gene mutated alone (NS = not significant, F1 = 1st generation,
F2 = 2nd generation, F3 = 3rd generation).

Pax3LacZ/+ x EdnrbS-l/+

Average of
Hypopigmentation of
Single Heterozygous

Average of
Hypopigmentation of
Double Heterozygous

F1

45.0

349.1

F2

125.5

477.8

F3

84.0

340.0

Table 2.6 Sums of Averages. The sum of hypopigmentation averages for
single heterozygous animals (Pax3LacZ/+ x EdnrbS-l/+) compared to the
hypopig-mentation
average
for
double
heterozygous
siblings
(Pax3LacZ/+::EdnrbS-l/+). Levels of significance are listed by statistical measure
used in Table 1. (F1 = 1st generation, F2 = 2nd generation, F3 = 3rd generation).
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III. TRANSGENIC EXPRESSION OF ENDOTHELIN RECEPTOR B RESCUES
THE HYPOPIGMENTATION PHENOTYPE OF SOX10 AND PAX3
HETEROZYGOUS MICE
1. Abstract
Given the synergistic effect of Sox10 and Ednrb as well as Pax3 and
Ednrb on the hypopigmentation phenotype of mice carrying mutations in these
genes, I investigated the effects of a transgenic addition of Ednrb to melanocyte
precursors. Using a transgene that uses the Dopachrome tautomerase (Dct)
promoter to selectively deliver Ednrb to melanoblasts, I first elucidated the
effect of delivering additional Ednrb to the melanocyte precursors in Sox10LacZ
and Pax3Sp mutant mice. Coat color was completely restored in the
Sox10LacZ/+::Dct-Ednrb mice and partially restored in the Pax3Sp/+::Dct-Ednrb
mice. Then, I compared melanoblast development in Sox10 mutant mice with
and without this Dct-Ednrb transgene by harvesting embryos at E11.5 and
E12.5, a critical time in melanoblast expansion, and comparing the amount of
melanoblasts between transgenic and non-transgenic embryos. The transgenic
addition of Ednrb rescued melanocyte precursors in Sox10 heterozygous
animals but not in Sox10 homozygous animals. Cell survival assays indicate
that the rescue is not due to an effect of the transgene on melanoblast survival.
In conclusion, my data demonstrates that both Sox10 and Pax3 interact with
Ednrb in the development of the melanocyte lineage. Transgenic expression of
additional Ednrb may compensate for the detrimental effects of Sox10
haploinsufficiency in this lineage, and the reduced number of melanocyte
precursors in Sox10 mutants is not due to increased apoptosis.
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2. Introduction
The results described in Chapter 2 established a synergistic genetic
interaction between the transcription factors Sox10 and Pax3 and the Gcoupled receptor Ednrb. By crossing Sox10 or Pax3 heterozygotes with Ednrb
heterozygotes, a clear aggravation of the pigmentation phenotype was
observed. To further explore these genetic interactions, I will use a transgenic
mouse that puts the delivery of Ednrb under the control of the Dct promoter to
attempt the rescue of the hypopigmentation phenotype of the Sox10 and Pax3
mutants.
The first transgenic mouse was created in mid-1980’s (Palmiter and
Brinster, 1985) and opened the way to examine genes and their mutations at
the organismal level. Transgenically, genes can be manipulated to cause loss
of function, gain of function, the addition of a new gene or exploration of
activation and/or deactivation of genes during critical times of gene expression.
This ability to modulate gene expression in vivo enables elucidation of the
cascade of genetic interactions and eventually helps us determine whether
these interactions are direct, indirect or working along parallel pathways.
Untangling of genetic interactions is often difficult due to the complex, nonlinear influences that genes and other modulating factors have on each other’s
expression. For example, the C57BL/6J background diminishes the penetrance
of

the

EdnrbS-l/+

hypopigmentation

phenotype

while

augmenting

the

aganglionosis of Sox10Dom/+ mice when compared to other background strains
(Cantrell et al., 2004).
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Gene expression in higher eukaryotes is predominantly regulated by
transcriptional control; and it is this highly coordinated, tightly controlled
activation and deactivation of genes that dictates cellular differentiation. A direct
genetic interaction implies that one gene binds directly with another gene, as in
the case of Sox10 and Mitf where Sox10 binds to the proximal region of the Mitf
promoter activating it in melanoblasts (Bondurand et al., 2000; Hornyak et al.,
2001; Potterf et al., 2000). An example of an indirect genetic interaction is that
of Sox5 and Sox10: Sox5 binds and recruits CtBP2 and HDAC1 as
transcriptional co-repressors that bind to the Sox10 regulatory region thereby
decreasing Sox10 activity (Stolt et al., 2008). In some cases, mutations in
multiple genes can cause a disease without ever interacting with each other as
in the case of Hirschsprung’s disease whereby mutations in Ret (Edery et al.,
1994) or mutations in Ednrb (Puffenberger et al., 1994) result in similar disease
phenotypes. In addition to these possibilities, enhancer regions can have
binding sites for multiple transcription factors. This complexity adds to the
difficulty of deciphering specific gene functions, sometimes necessitating more
than one approach in order to elucidate whether or not an interaction exists.
In one study Sox10 was shown to bind directly to an Ednrb enhancer in
migrating murine enteric neuroblasts (Zhu et al., 2004). In fact, Sox10 had 3
binding sites on the Ednrb enhancer and depending on the binding site(s) that
were affected and the extent of the mutation, the penetrance and variability of
the phenotype appeared to be affected. The pigmentation phenotype was not
rescued suggesting that Sox10 regulation of Ednrb through this particular
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enhancer might function in enteric neurons and not in melanoblasts. However
in another study, the expression of EDNRB in human melanocytes appeared
directly dependent on Sox10 (Yokoyama et al., 2006). In fact in the presence of
Sox10 siRNA, EDNRB protein was reduced by 46% and the presence or
absence of Sox10 affected EDNRB promoter activity. Three putative SOX10
binding sites on the EDNRB promoter were evaluated and all three dramatically
influenced EDNRB expression. Another transcription factor, Sp1, was found to
work in conjunction with Sox10 to upregulate EDNRB even more than SOX10
alone and may contribute to specificity of SOX10 activation in the melanocyte
lineage.
Using a transgene is another way in which to evaluate whether or not
genetic interactions exist: typically a transgene adds to the genome but can
also replace a gene, either entirely or partially, essentially creating a knock-out
or knock-in mutant depending on the resulting gene expression. The Dct-Ednrb
transgene used here delivers additional Ednrb to the Dct expressing
melanoblasts of the murine embryo with expression at E11.5 confirmed (Ittah,
2005). Dct has been previously shown to start being expressed during E11.5 –
E12.5 (Mackenzie et al., 1997; Potterf et al., 2001; Steel et al., 1992) and is a
well know melanoblast marker (Hornyak et al., 2001; Zhao and Overbeek,
1999). In fact, the Dct promoter has been used before to successfully deliver
specific genes to melanoblasts (Hakami et al., 2006; Zhao and Overbeek,
1999) and also to track migrating melanoblasts (Silver et al., 2008).
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Recently, a Sox10 transgene was put under the control of the Dct promoter
to see if additional Sox10 in an Ednrb mutant mouse could rescue the
hypopigmentation phenotype (Hakami et al., 2006). While, the Dct-Sox10
transgene was able to adequately rescue Sox10 heterozygosity (implying that
the transgene correctly targeted Sox10 positive cells), the Dct-Sox10 transgene
was unable to rescue the pigmentation phenotype of EdnrbS-l/+ mice. In this
study I will attempt to rescue the Sox10LacZ/+ hypopigmentation phenotype via
the Dct-Ednrb transgene. If the transgenic addition of Ednrb can rescue the
hypopigmentation of Sox10 heterozygosity, these results taken together with
those results from Hakami et al. (2006), will imply that Sox10 directly regulates
Ednrb expression during the critical window of melanoblast expansion.
3. Materials and Methods
3.1 Animals and Genotyping
Sox10LacZ, Pax3Sp and Ednrbs-l animals were maintained and genotyped as
described in Chapter 2. Sox10LacZ/LacZ are embryonic lethal at approximately
E13.5; since embryos were harvested at E11.5 and E12.5 developmental
changes in the Sox10 homozygous condition were observed (Appendix II.C).
Staged embryos were dated 0.5d at noon the day of vaginal plug. Embryos
were harvested by euthanizing the pregnant dam via cervical dislocation and
dissecting embryos through a transverse abdominal incision. Embryos were
immediately placed in PBS (the pH of which was determined by the subsequent
procedure, see Appendices II.D and II.H) and yolk sacs were saved for DNA
extraction (Appendix II.B). Those destined for double staining with LysoTracker
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Red and LacZ, were immediately started on that protocol (Appendix II.H).
Embryos for in situ hybridization were dehydrated through a methanol (MeOH;
Fisher

Scientific)

series

(25%:75%

MeOH:PBS;

50%:50%;

75%:25%

MeOH:PBS for 5min each) and stored in 100% MeOH at -20ºC.
Dct-Ednrb transgenic animals were generated in our laboratory (Avner Ittah,
FIU dissertation 2005). The full length Ednrb cDNA (1958bp, genbank
accession # U32329) obtained from pmET-B (Hosoda et al., 1994) was inserted
into the vector pmDct that contains 3431 bp of the mouse Dct promoter and the
BGH poly adenylation signal (Hornyak et al., 2000). Dct-Ednrb transgenic mice
were generated by microinjection of the transgene into FVB F1 zygotes. The
studies presented here were carried out with a line that initially had 150 copies
of the transgene. This line was crossed for over 10 generations with C57BL/6J
mice from our colony. Mice were genotyped using 1µM of each primer DctEdnrbf

(5’-ACAAGGAAGACTGGCGAGAA-3’);

and,

Dct-Ednrbr

(5’-

TCCTCCCCCTTGCTGTCCTGC-3’; Invitrogen), 1X buffer, 2mM MgCl, 1 unit
Taq (Bioline), 5% DMSO (Fisher Scientific), 2.5mM of each dNTP (Invitrogen)
and 1µl DNA. The amplified DNA was visualized on a 1% agarose gel resulting
in a 2217bp band (Appendix I).The PCRs were performed for 35 cycles under
the following conditions: 94C for 30 s, 57C for 30 s, and 72C for 2 min.
All animals used in this study were housed in the Animal Care Facility at
Florida International University (Miami, FL). Water and murine chow were fed
ad libitum and light/dark was cycled every 12 hours. All animal work was
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performed according to institutional guidelines established by NIH (Guide for
the Care and Use of Laboratory Animals, 2009; IACUC protocol # 08-001).
3.2 Crosses and Phenotype Analysis
Sox10LacZ/+ mice were crossed with Dct-Ednrb mice to produce offspring
that were Sox10LacZ/+::Dct-Ednrb. These transgenic Sox10LacZ/+ mice were
examined for the presence of pigmentation defects over the course of 4
generations. Pax3Sp/+ mice were also crossed with Dct-Ednrb mice to produce
offspring that were Pax3Sp/+::Dct-Ednrb in order to evaluate potential changes in
pigmentation defects for 1 generation.
Sox10LacZ/+::Dct-Ednrb mice were crossed to each other to produce E11.5
and E12.5 embryos that were Sox10LacZ/LacZ::Dct-Ednrb and Sox10LacZ/+::DctEdnrb. Sox10LacZ/LacZ (with or without the transgene) often times disintegrated
during dissection or during the procedures of in situ hybridization or Lysotracker
Red/LacZ but all embryos, regardless of presentation or staining, were
genotyped.
3.3 In Situ Hybridization
In situ hybridization (ISH) was performed on E11.5 embryos using the
Pmel17 riboprobe. Pmel17 is a highly sensitive and early melanoblast marker
with expression starting at E9.5 (Baxter and Pavan, 2003). The full length
cDNA (1935bp, genbank accession number M77348) was inserted into DH5α
Escherichia coli and this plasmid was purified and linearized prior to Pmel17
riboprobe synthesis (Appendix II.E). Pmel17 structure and homology to other
melanocytic markers has been previously described by Kwon et al. (1991).
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On day 1 of ISH, embryos were rehydrated via a MeOH series using PBT*
(PBS** plus 0.1% Tween-20; Fisher Scientific) 5min for each of the following
steps: 75%:25% MeOH:PBT; 50%50%; 25%:75% MeOH:PBT and two washes
in 100% PBT. Embryos were then bleached in 6% H2O2 (Fisher Scientific) in
PBT for 1hr at RT and then permeabilized using 10µg/ml proteinase K
(Promega) in PBT (15min for E11.5 and 18min for E12.5). To neutralize this
reaction, 2mg/ml glycine (Fisher Scientific) in PBT was added for 10min at RT
and then washed twice with PBT. Embryos were postfixed with 4%
paraformaldehyde (Fisher Scientific), 0.2% gluteraldehyde (Sigma) in PBT for
20min. Pre-hybridization was accomplished by adding 1ml hybridization
solution (50% formamide, 5xSSC pH4.5 1% SDS, Fisher Scientific; 50µg/ml
yeast tRNA, Sigma; 50µg/ml heparin, Sigma) and incubated in a 70ºC water
bath for 1hr. The pre-hybridization solution was removed and fresh
hybridization solution containing 2µl Pmel17 riboprobe per ml of hybridization
solution added and left overnight in the 70ºC water bath.
Day 2 consisted of embryos being briefly rinsed in solution 1 (50%
formamide, 5xSSC and 1%SDS; Fisher Scientific) and then washed 3 times
more with solution1 (30min each time in a 70ºC water bath). Washing was
continued, 3 more times, using solution 2 (50% formamide and 2xSSC; Fisher
Scientific) and placed in a 65ºC water bath for 30min each time, followed by
washing with TBS plus 0.1% Tween-20 (TBST) 3 times for 5min each time.
Blocking of embryos in 10% goat serum (Fisher Scientific) in TBST for 2hrs,
rocking at RT, during which time the preabsorb anti-digoxigenin antibody was
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prepared by adding a pinch of embryo powder to microcentrifuge tubes
containing 0.5ml TBST (1 microcentrifuge tube/embryo) and placed in 70ºC
water bath for 30min. Microcentrifuge tubes were removed from water bath,
vortexed and cooled prior to the addition of 5µl of 100% goat serum and 1µl
anti-digoxigenin antibody (Roche) and rocked at 4ºC for 1hr. After centrifuging
for 5min, the supernatant was collected and 1.5ml of 1% goat serum in TBST
per microcentrifuge tube was added. When embryos were ready, the blocking
solution was removed, the antibody solution added and embryos were left
rocking overnight at 4ºC.
To remove the antibody, on day 3 embryos were briefly rinsed in TBST and
then washed 4 times in TBST for 1hr each time at RT. Levamisole (2mM;
Sigma) was added to a 5th TBST wash and left overnight, rocking at 4ºC.
Finally, day 4 was the detection of the antibody in which the embryos were
washed in NTMT (100mM NaCl, 100mM Tris pH9.5, 50mM MgCl2, 0.1%
Tween-20; Fisher Scientific; 2mM levamisole; Sigma) 3 times for 10min each
time. While protecting from light, 45µl 4-Nitro blue tetrazolium chloride (NBT;
Roche) and 35µl 5-Bromo-4-chloro-3-indolyl-phosphate (BCIP; Roche) were
added to 10ml NTMT and added to each embryo. Still protected from light,
embryos were monitored every 30min to control the level of antibody
development (Wilkinson 1998).
Cells labeled with the Pmel17 probe that were located in the torso were
counted from a picture taken of the area at 3.2x magnification. The angle of
lines drawn to define the area intersected the posterior aspect of the forelimb
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and the anterior aspect of the hindlimb. Lines drawn to define the area, lighting
and magnification were kept constant for all pictures taken.
3.4 LysoTracker Red and LacZ Staining
Embryos were dissected and rinsed in cold 0.05M PBS (pH7.2) and placed
in 5µM LysoTracker Red DND-99 (Invitrogen), protected from light, at 37ºC for
30min. Continuing to protect the embryos from light, they were washed twice in
PBS, 2% paraformaldehyde (PF; Fisher Scientific) for 1hr at room temperature
(RT), washed twice more with PBS and then left overnight at 30ºC in LacZ
solution (5µM ferricyannide, 5µM ferrocyannide, 2mM MgCl2, 0.01% sodium
deoxycholate (Fisher Scientific), 0.02% nonidate p-40 (Roche) and 1mg/ml Xgal (Invitrogen). Rinsed twice in PBS to stop reaction and a 10% sucrose
(Fisher Scientific) solution was added to embryos for overnight incubation at
4ºC, rocking gently. Finally, embryos were placed in 20% sucrose solution for
4-6hrs and embedded in Tissue-Tek Tissue Freezing Medium (Sakura).
Embryos were stored at -80ºC.
Transverse cryosections of 10µm were taken of embryos from the brachial
nerve to the sciatic nerve. Every third section was kept from E11.5 embryos
while every 4th section was kept from E12.5 embryos. Of these sections, 30
equally spaced sections (e.g. every other section) were selected for counting.
Cells that were blue (LacZ+), elongated and appeared to be traveling along the
dorsolateral pathway were counted and checked for double labeling with
Lysotracker Red.
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4. Results
4.1 Dct-Ednrb Transgene Rescues the Sox10LacZ/+ and Partially Rescues
the Pax3Sp/+ Hypopigmentation Phenotypes
The transgenic delivery of Ednrb to the melanoblasts of Sox10LacZ/+ revealed
that the hypopigmentation caused by Sox10 heterozygosity can be rescued by
additional Ednrb (Figure 1). In fact, while 47% (n=83) of Sox10LacZ/+ mice did
not exhibit ventral hypopigmentation (53% did; n= 95); 100% (n=33) of the
Sox10LacZ/+ carrying the transgene had fully colored coats (Table 1).
In contrast, the Pax3Sp/+ hypopigmentation was only partially rescued by the
transgene. The hypopigmentation defect of Pax3Sp/+ is completely penetrant; all
Pax3 heterozygous mice have ventral hypopigmentation. Pax3Sp/+::Dct-Ednrb
mice exhibited no hypopigmentation 24% (n=5) of the time and a partial rescue
(considerably smaller area of hypopigmentation) 10% (n=2) of the time. The
other

66%

of

the

animals

displayed

typical

Pax3

heterozygous

hypopigmentation (Figure 2, Table 2).
4.2 Transgenic Embryos Show Increased Numbers of Melanoblasts
In situ hybridization using Pmel17 as a marker shows an increased number
of melanoblasts in the transgenic embryos when compared to the nontransgenic embryos of the same genotype (Table 3). Easily apparent in E11.5
embryos, counts taken of trunk melanoblasts supports this observation.
Comparison of Sox10LacZ/+ embryos to Sox10LacZ/+::Dct-Ednrb embryos results
in a significant increase in trunk melanoblasts (p=0.04). Unexpectedly, an even
more significant increase in trunk melanoblasts (p=0.01) was seen when
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comparing wildtype (Sox10+/+) embryos to transgenic wildtype (Sox10+/+::DctEdnrb) embryos. Three embryos were counted for each genotype (Figure 3).
4.3 Increased Numbers of Melanoblasts in Transgenic Embryos Cannot
Be Accounted for by an Effect on their Survival
Double staining with LysoTracker Red and LacZ indicate that the increased
numbers of melanoblasts observed in transgenic embryos is not due to a
putative role of the transgene in preventing the apoptosis of melanoblasts in
Sox10LacZ/+ embryos at E11.5 and E12.5. LacZ+ cells traveling along the
dorsolateral pathway that were morphologically identified as melanoblasts were
counted and then checked to see if they were double labeled with LysoTracker
Red (Tables 4 and 5). While cell death was seen throughout the embryo in a
characteristic pattern, there were very few LacZ+ cells that also stained positive
for LysoTracker Red (figures 4 and 5). In fact, in E11.5 embryos it was very
rare that a cell was double stained for LacZ and LysoTracker Red (Table 4).
11.5 day old homozygous Sox10 embryos rarely had a LacZ+ cell while the
transgenic Sox10 homozygous embryo did have a few (between 4 and 16)
LacZ+ cells but there was no significant difference (p=0.26). Sox10
heterozygous embryos had LacZ+ 38-67 cells but the transgenic Sox10
heterozygous embryos had significantly more LacZ+ cells (135-180 cells;
p=0.003).
Rapid increase in the amount of these LacZ+ (presumptive melanocytic)
cells was seen when comparing numbers obtained from E11.5 (Table 4) and
E12.5 (Table 5) embryos. Interestingly, not only do the numbers increase
tremendously in the Sox10LacZ/+ embryos from E11.5 to E12.5 (with or without
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the transgene), but the number of cells increased somewhat in the homozygous
embryos as well. In the E12.5 Sox10LacZ/+ embryos, the number of LacZ+ cells
increased significantly in the transgenic heterozygous embryos (p=0.012) when
compared to the heterozygous embryos without the transgene; while in the
homozygous embryos there was no significant difference in the number of
LacZ+ cells between Sox10LacZ/LacZ and Sox10LacZ/LacZ::Dct-Ednrb. There were
several more double stained cells (0-20) at this age in the heterozygous
embryos but this seemed to be relative to the total number of LacZ+ cells
observed. Sox10 homozygous mutants were difficult to obtain at E12.5 as they
often disintegrated during dissection or during the staining process.
5. Discussion
In vivo analysis of coat color and embryonic melanoblasts indicated that the
Sox10 hypopigmentation phenotype was consistently rescued by the transgenic
addition of Ednrb; in the case of Pax3 hypopigmentation phenotype the
additional Ednrb conferred a partial rescue on coat color. Sox10, which is
colocalized with Ednrb, may be required as premigratory melanoblasts emerge
to ensure melanoblast survival and differentiation (Potterf et al., 2001). Dct, a
well known melanocyte marker (Hornyak et al., 2001; Zhao and Overbeek,
1999), is partially regulated by Sox10 (Jiao et al., 2004; Ludwig et al., 2004;
Potterf et al., 2000) so that in Sox10 heterozygous mice the level of Dct
expression is less than it would normally be in melanoblasts of wildtype mice.
Sox10 is known to activate Mitf, a major melanocyte-specific transcriptional
regulator and Mitf in turn regulates Dct expression (Bondurand et al., 2000;
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Yokoyama et al., 2006). In the case of Sox10 heterozygosity, Mitf activation is
diminished as is Dct expression with Dct expression being affected by
decreased levels of both Sox10 and Mitf. In Sox10Dom/+ embryos, Dct
expression is greatly reduced but melanoblasts still populate the embryo in a
temporally and spatially correct manner with a dramatic increase in Dct
expression at E13.5 and normal melanoblast population by E14.5 (Potterf et al.,
2001). Melanoblasts in Sox10LacZ/+ embryos also appear to migrate in a
temporally and spatially correct manner at E11.5 and E12.5.

Sox10

haploinsufficiency must provide sufficient Ednrb activation so that melanoblasts
migrate normally and populate most of the embryo, except for the ventral
aspect. Trunk melanoblasts migrate at a later time than do other melanoblast
populations (Serbedzija et al., 1990; Yoshida et al., 1996) and therefore may
have a later requirement for Ednrb. Since the critical window for Ednrb
expression in melanoblasts lasts through E12.5, the use of a Dct promoter,
whose expression begins at E11.5, appears to act early enough to compensate
for the decreased amount of Sox10 activity and rescue the melanoblasts.
While a Dct-Sox10 transgene could not rescue the hypopigmentation
phenotype of EdnrbS-l/+ (Hakami et al., 2006), the Dct-Ednrb transgene
consistently rescued the hypopigmentation phenotype of the Sox10LacZ/+ mice.
Dct-Sox10 adds more Sox10 to a system with limited Ednrb. It may be that
once the limited amount of functional Ednrb has been fully activated by Sox10
the addition of more Sox10 does nothing because there are no more binding
sites available on Ednrb. Conversely, the transgenic addition of Ednrb to a
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Sox10LacZ/+ does what Sox10 would have normally done – provide sufficient
levels of Ednrb signaling to promote proper melanoblast dispersal and thereby
rescues the hypopigmentation phenotype of the Sox10 heterozygous mutant.
Pax3Sp/+

mutants,

which

exhibit

a

completely

penetrant

ventral

hypopigmentation phenotype, experienced a partial rescue with the Dct-Ednrb
transgene. Present by E8.5 (Goulding et al., 1991), Pax3 is important in the
initiation of the melanogenic pathway while simultaneously acting in the
prevention of terminal differentiation (Lang et al., 2005). Similar to Sox10, Pax3
activates Mitf (which then activates Dct) but unlike Sox10, Pax3 competes with
Mitf for binding sites on Dct (Fuchs et al., 2004; Potterf et al., 2000; Yasumoto
et al., 2002). Dct expression is normal in Pax3Sp/+ embryos at E11.5 indicating
that Dct expression is not affected by Pax3 haploinsufficiency (Potterf et al.,
2001). Prior to Mitf activation of Dct, Mitf is present in the dorsal aspect of the
neural tube and is important in the survival of premigratory melanoblasts shortly
before they reach the MSA and for a short while after they start migrating
(Hornyak et al., 2001). It is possible therefore, that Pax3 may exert influence
over the expression of Mitf at this early stage (E8.5-E10.0) as well and that the
hypopigmentation phenotype seen in Pax3 heterozygous mice is at least
partially due to this early insult on Mitf. If melanoblasts are more severely
affected by decreased levels of Pax3 at the premigratory phase rather than
later once Dct is expressed, then the transgenic expression of Ednrb may be
too late to rescue coat color in the Pax3 mutant.
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In order to elucidate the timing of the rescue in Sox10LacZ/+ embryos, in situ
hybridization with Pmel17 was performed on E11.5 as this is the first time
melanoblasts are migrating throughout the length of the embryo. Pmel17
hybridizes to a larger number of murine melanoblasts than does Dct and at an
earlier age (E10.5 vs. E11.5), as presumptive melanoblasts are starting to
emerge (Baxter and Pavan, 2003). Initially identified in human and murine DNA
(Kwon et al., 1991), Pmel17 is now used in a variety of animals including
horses (Brunberg et al., 2006), dogs (Clark et al., 2006) and chickens (Kerje et
al., 2004) to study pigmentation genetics. Sensitivity of Pmel17 to identify
melanoblasts may be due to the fact that it is the only melanosomal component
that has membrane bound and soluble forms (Valencia et al., 2006), possibly
making detection easier.
The Pmel17 promoter is not regulated by Sox10 (Loftus et al., 2009)
implying

that

expression

of

Pmel17

is

not

influenced

by

Sox10

haploinsufficiency. In addition to its early expression, being Sox10-independent
makes Pmel17 an excellent candidate for identifying whether or not the
transgenic addition of Ednrb into a Sox10 heterozygote increases the number
of melanoblasts. By E11.5, significant differences in the number of
melanoblasts were seen between Sox10LacZ/+ and Sox10LacZ/+::Dct-Ednrb
embryos and interestingly, between wildtype and wildtype transgenic embryos.
It appears that increasing the amount of Ednrb in the melanocyte lineage allows
for greater expansion of migrating precursors.
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Since the LacZ reporter gene has been knocked into the Sox10 locus,
migrating melanoblasts (and other Sox10 positive cells) can be easily identified.
Double staining of embryos was employed to explore whether the melanoblast
density difference between transgenic and non-transgenic embryos was due to
increased apoptosis in the non-transgenic embryos. As this was not the case,
the increased numbers of melanoblasts in transgenic embryos may be due to a
variety of reasons. The Dct-Ednrb transgene may have compensated for the
lack of Sox10 activation by saturating the system with Ednrb thereby increasing
any survival component that Ednrb bestows on melanoblasts as they emerge
from the MSA. Since Ednrb appears to be required for the migration of
emerging melanoblasts (Shin et al., 1999), the additional Ednrb may have
compensated for the haploinsufficient Sox10 activation of Ednrb and may
ensure proper melanoblast migration. And finally, given that Edn3, the preferred
ligand for Ednrb, is a known proliferative agent for this lineage (Lahav et al.,
1996) perhaps the increase in functional receptor allowed for an increase in
Edn3 proliferative action resulting in an even larger number of melanoblasts at
E11.5 and E12.5. Taken together, these results support the direct interaction of
Sox10 and Ednrb because it is the Sox10 activation of Ednrb which enables the
receptor to promote survival, migration and subsequently the proliferation of
emerging melanoblasts needed to rescue the pigmentation phenotype.
While Sox10 and Pax3 work together to transactivate Mitf in the melanocyte
lineage, it appears that the relationship of Pax3 to Ednrb is more complex than
that of Sox10 and Ednrb. As shown earlier, mice harboring both Pax3Sp/+ and
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EdnrbS-l/+ mutations exhibited aggravated pigmentation phenotypes (Chapter
2), yet there is only a small partial rescue of the coat color with the transgenic
addition of Ednrb in the Pax3Sp/+ mutant. Perhaps an interaction between Pax3
and Ednrb does exist but in a much more indirect fashion with one or more
intermediate transcription factors or signaling pathways in the genetic cascade.
Or perhaps the insult of Pax3 haploinsufficiency on neural crest specification is
too great for Ednrb to rescue. And finally, it is possible that the Dct promoter
used to deliver the Ednrb becomes active too late to completely rescue
melanoblasts from their Pax3 deficiency. Any of these possibilities would
explain the increased hypopigmentation of the double mutant and the lack of
rescue using the Dct transgene.
In conclusion, the complete rescue of hypopigmentation in the Sox10
heterozygote supports an interaction between Sox10 and Ednrb in the
melanocyte lineage. Still unclear is the mode of rescue although there may be a
putative survival effect of the transgene by E11.5. Future experiments should
include looking earlier in development to evaluate whether or not cell death is
occurring prior to E11.5 in Sox10 heterozygous mice. Proliferation assays (such
as labeling with P-Histone3) from the time that premigratory melanoblasts
emerge from the MSA until E12.5 when melanoblasts have populated the entire
length of the embryo may help illuminate the mode of rescue as well. In regards
to the Pax3 heterozygous condition, the possible interaction between Pax3 and
Ednrb remains elusive. Evaluating possible effects of Pax3 haploinsufficiency
on neural crest specification and on Mitf expression prior to and during the time
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premigratory melanoblasts begin their journey may help elucidate any
interaction, albeit indirect, between Pax3 and Ednrb in the melanocyte lineage.

Figure 3.1 Transgenic rescue of the Sox10LacZ/+ pigmentation phenotype.
(A)Typical hypopigmentation of Sox10LacZ/+ mice. (B)The targeted addition of
Ednrb to the melanocyte precursors consistently rescued the hypopigmentation
phenotype of Sox10LacZ/+ mice.
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Table 3.1 Complete rescue of Sox10LacZ/+ pigmentation phenotype by DctEdnrb transgene. Targeted addition of Ednrb to melanoblasts rescues the
pigmentation phenotype in Sox10 heterozygous mice 100% of the time.
Homozygous Sox10 embryos did not have rescued melanoblasts and were still
embryonic lethal, possibly due to the more serious developmental anomalies
incurred by the near complete absence of Sox10. BS = Belly Spot.

Figure 3.2 Dct-Ednrb transgene partially rescues the Pax3Sp/+ pigmentation
phenotype. (A) Mice who did inherit the transgene have the characteristic
Pax3Sp/+ pigmentation; transgenic delivery of Ednrb (B) completely rescues the
Pax3Sp/+ pigmentation phenotype 24% of the time and (C) partially rescues 10%
of the time. (D) The transgene was not able to rescue 66% of the time.
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Table 3.2 Transgenic expression of Ednrb partially rescues the Pax3Sp/+
phenotype. Targeted addition of Ednrb to melanoblasts rescues the
pigmentation phenotype in Pax3 heterozygous mice nearly a quarter of the time
and partially rescues 10% of the time. The transgene was not able to rescue
melanoblasts in homozygous embryos, possibly due to the more serious
developmental anomalies caused by the absence of Pax3, such as the lack of
structures and tissues necessary to support life. BS = Belly Spot.
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No Tg

Tg

Sox10LacZ/+
161
229
108
279
255
305

Sox10+/+
325
445
385
623
613
531

Table 3.3 Pmel17 labeled trunk melanoblasts. Cell counts for each of the
embryos in which trunk melanoblasts were counted show an increase in the
number of melanoblasts in the transgenic counterpart for each genotype:
Sox10LacZ/+ vs. Sox10LacZ/+::Dct-Ednrb and Sox10+/+ vs. Sox10+/+::Dct-Ednrb.
Tg = Transgene.

94

95

E

Figure 3.3 In situ
hybridization with Pmel17
riboprobe shows increased
numbers of truck
melanoblasts in transgenic
embryos at E11.5. Nontransgenic embryos of both
(A) Sox10LacZ/+ and (B)
wildtype embryos have
fewer melanoblasts than
their (C, D) transgenic
counterparts. (E) Pmel17
labeled cell count shows
transgene increases
number of melanoblasts in
Sox10LacZ/+ and in wildtype
embryos. In each condition,
the presence of Dct-Ednrb
significantly increased the
number of melanoblasts.
Sox10LacZ/+ vs. Transgenic
Sox10LacZ/+, p=0.04;
wildtype vs. transgenic
wildtype p=0.01. Three
embryos were counted for
each condition. No Tg = No
Transgene; Tg =
Transgene.
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No Tg

Tg

Sox10LacZ/LacZ
1*/0**
0
0
4/0
16/1
0

Sox10LacZ/+
67/0
38/0
38/0
143/0
180/0
135/0

Table 3.4 Transgenic rescue of Sox10 haploinsufficient cells is not due to an
effect on melanoblast survival at E11.5. LacZ and LysoTracker Red double
stained Sox10 positive cells indicate that apoptosis is not the cause of
decreased melanoblasts in E11.5 embryos. It is a rare cell in E11.5 embryos
that is stained by LacZ and also stained by Lysotracker Red, even though
ample cell death is seen throughout the embryo. *Number of LacZ+ cells;
**Number of LysoTracker Red+ cells. No Tg = No Transgene; Tg = Transgene.
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Figure 3.4 LacZ staining of E11.5 Sox10 embryos shows transgenic rescue of
melanoblasts in Sox10 heterozygotes. (A,B) Sox10 homozygous embryos
appear void of melanoblasts in the truck region, (E,F) regardless of transgenic
expression of Ednrb. (C,D,G,H) In reality, homozygous embryos with or without
the transgene have very few if any melanoblasts, none of which stained
positive for LysoTracker Red. Melanoblasts are seen populating the trunk
region in (I,J) Sox10LacZ/+ embryos; (M,N) Sox10 heterozygous embryos exhibit
a large increase in the number of melanoblasts in transgenic animals. (K,L,O,P)
Again, none of the melanoblasts were double labeled with LysoTracker Red
implying that the difference in melanoblast numbers is not due to increased cell
death at E11.5.
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No Tg

Sox10LacZ/LacZ
7/0
19/6
12/0
17/0

Sox10LacZ/+
166/4
207/0
148/0
987/10
622/6
1216/20

Tg

Table 3.5 Transgenic rescue of Sox10 haploinsufficient cells is not due to an
effect on melanoblast survival at E12.5. LacZ and LysoTracker Red double
stained Sox10 positive cells indicate that apoptosis is not the cause of
decreased melanoblasts in E12.5 embryos. Very few cells in E12.5 embryos
that are stained by LacZ are also stained by Lysotracker Red, even though
ample cell death is seen throughout the embryo. *Number of LacZ+ cells;
**Number of LysoTracker Red+ cells. No Tg = No Transgene; Tg = Transgene.
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Figure 3.5 LacZ staining of E12.5 Sox10 embryos shows transgenic rescue of
melanoblasts in Sox10 heterozygotes. (A,B) Homozygous Sox10 embryos have
relatively few melanoblasts that can be seen in (C) cryosections. (E,F) Sox10
heterozygous embryos had visible melanoblasts that were also better
visualized in (G) cryosections. (I,J,K) Transgenic Sox10 heterozygous embryos
had significantly more melanoblasts than non-transgenic heterozygous
embryos. (D,H,L) No significant cell death was seen in any of the embryos
regardless of genotype.
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CROSS BETWEEN EdnrbS-l AND Pax3Sp RESULTS IN A NOVEL
PHENOTYPE: HYDRCEPHALUS AND INTERRMITTENT
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IV. CROSS BETWEEN EdnrbS-l AND Pax3Sp RESULTS IN A NOVEL
PHENOTYYPE: HYDROCEPHALUS AND INTERMITTENT SKELETAL
DEFORMITIES
1. Abstract
A novel phenotype arose when studying the potential interaction between
Ednrb and Pax3. All pups were born normal in appearance and behavior but by
3 to 3.5 weeks of age, the affected pups were smaller than their normal
littermates and developed a dome-shaped head; some also developed distinct
thoracic kyphosis. All affected pups were dead by 4 weeks of age except one
which survived until the 8th week of life. The goal of this study was to
describe the basic characteristics seen in affected pups. Seventy-five
percent of affected pups were female although there was no gender bias based
on genotype or generation. Of the affected animals, 80% were heterozygous for
Pax3. Upon histologic examination, brains of affected mice had an enlarged 4th
ventricle and increased glial processes when compared to brains of normal
littermates. Skeletal staining showed kyphosis and rounded wide rib cages in
those animals which developed skeletal abnormalities. An epistatic interaction
resulting from the mixing of genetic backgrounds that is potentially exacerbated
in the presence of Pax3 heterozygosity is suspected.
2. Introduction
Endothelin receptor b and Pax3 are involved in early NC development and
mutations in either one result in similar phenotypes, such as a decrease in
melanocytes or the presence of variant forms of Waardenburg’s Syndrome
(WS) (2001; Read and Newton, 1997; Tassabehji et al., 1994). Pax3
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heterozygous mice have a completely penetrant ventral hypopigmentation
phenotype; Ednrb heterozygous mice often have hypopigmentation while the
homozygous mutants are almost completely white (Hornyak et al., 2001; Pavan
and Tilghman, 1994). As detailed in chapter one (Figure 1), Pax3 and the
Ednrb/Edn3 signaling pathway are both involved in the proliferation of
melanocyte progenitors.
Melanocyte numbers are dramatically reduced in mice that are Ednrb
homozygotes (Hosoda et al., 1994; Hou et al., 2004). In addition to the
reduction of skin melanocytes, these animals are often deaf due to the absence
of melanocytes in the stria vascularis of the inner ear (Matsushima et al., 2002)
and typically die in the neonatal period due to aganglionosis which arises as a
consequence of improper innervation of the gut by enteric neuronal precursors
(Lee et al., 2003; Shin et al., 1999). Endothelin receptor b has been suggested
to be an essential migration factor for the emerging neural crest cells from
E10.5-12.5 (Shin et al., 1999). Expressed by a variety of cells along the
migratory path of the increasingly committed NC progenitor cells, Ednrb must
be functional in a cell autonomous fashion for melanoblasts to eventually
become pigmented and for correct spatial distribution of enteric neurons to
occur (Druckenbrod et al., 2008; Hou et al., 2004). Neither of these NC
derivatives can successfully reach terminal differentiation in the absence of
intrinsic Ednrb.
Pax3 is a critically important transcription factor during early embryonic
development with a temporally and spatially restricted expression pattern. Pax3

107

expression begins in the mouse embryo at E8.5 and is essential for patterning
of the vertebrate nervous system, melanocyte development and skeletal
muscle formation (Bajard et al., 2006; Goulding et al., 1991; Hornyak et al.,
2001). While Pax3 is known to be a necessary proliferative factor for emerging
melanoblasts, it also transactivates (along with Sox10) the major melanocyte
regulatory transcription factor Mitf (Bondurand et al., 2000; Hornyak et al.,
2001; Potterf et al., 2000). One of the most interesting features of Pax3 is that
as it activates Mitf it also serves as an inhibitor to Dct, a downstream target of
Mitf, thereby promoting the melanogenic cascade while at the same time
preventing terminal differentiation (Lang et al., 2005).
Development is the complex interaction of genes selectively being activated
and deactivated in a spatially and temporally restricted fashion in order to
dictate cell fate and specification. While Ednrb and Pax3 have several distinct
roles in embryonic development, in the melanocyte lineage they are expressed
at similar times and in similar locations, and indeed mutants have similar
pigmentation and disease phenotypes. This was the original impetus for
examining whether or not a genetic interaction existed between Ednrb and
Pax3 in the melanocyte lineage. In the previous study detailed in chapter 2, I
crossed EdnrbS-l/+ mice with Pax3Sp/+ mice to see if double heterozygosity
would affect the hypopigmentation phenotype. The hypopigmentation was
significantly aggravated in double heterozygous progeny in generations two
and three. While collecting data for this first study, a novel phenotype arose.
These mice were born looking normal but by 3.5-4 weeks of age appeared to
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have large dome-shaped heads, were hunched over and smaller than their
normal looking littermates. All affected animals died shortly after the
appearance of the domed head.
In this study, I wanted to examine the changes occurring both in the head
and skeletal structure of these animals. My aim was to provide a descriptive
account, in morphologic terms, of the alterations leading up to the certain death
of these animals. None of the affected animals survived.
3. Materials and Methods
3.1 Animals and Genotyping
Heterozygous Ednrbs-l on SSL/Le background and Pax3Sp on C57BL/6J
background were originally obtained from Jackson Laboratory and maintained
in the FIU Animal Care Facility. Heterozygous Ednrbs-l mice display small to
medium areas of ventral hypopigmentation while homozygous animals are
almost completely white, with small areas of pigmentation around the pinna and
base of the tail. Tail biopsies were used as sources of genomic DNA for PCR
genotyping (Appendix I.A). To detect the Ednrbs-l allele, the tightly linked
D14Mit7 microsatelite polimorphic marker (Metallinos et al., 1994) was used to
distinguish between Ednrbs-l and C57B/6J mice using conditions previously
described (Pavan and Tilghman, 1994; and Appendix I.B).

Pax3Sp animals

carry a point mutation within intron 3 of the paired homeobox 3 (Pax3) gene on
mouse Chromosome 1. The mutation interferes with normal splicing of intron 3
and leads to at least 4 aberrantly spliced mRNAs with exon 4 deleted. Pax3Sp
heterozygotes consistently display ventral hypopigmentation; mice homozygous
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for this mutation are embryonic lethal by E13.5. To genotype Pax3Sp mice, the
intron 3/exon 4 boundary of Pax3 was amplified with primers: P3in3F (5’GAGAGGGTTGAGTACGTTAGCTGG-3’)
CTCGCTCACTCAGGATGCC-3’).

Products

and
were

P3ex4
visualized

on

(5’a

15%

polyacrylamide gel resulting in a single band around 230bp for a wildtype and a
heteroduplex band at this same site for the heterozygote (Appendix I.B).The
PCRs were performed for 30 cycles under the following conditions: 94C for 30
s, 58C for 30 s, 72C for 30 s.
All animals used in this study were housed in the Animal Care Facility at
Florida International University (Miami, FL). Water and murine chow were fed
ad libitum and light/dark was cycled every 12 hours. All animal work was
performed according to institutional guidelines established by NIH.
3.2 Crosses and Phenotype Analysis
Crossing of EdnrbS-l/+ mice with Pax3Sp/+ mice resulted in mice of all
possible genotypes: EdnrbS-l/+, Pax3Sp/+, double heterozygous mutants
(EdnrbS-l/+ ::Pax3Sp/+) and wildtype for these mutations. While genotyping of all
animals was done, only characterization of progeny that exhibited the overt
phenotype in tandem with one normal littermate was undertaken. These
animals were euthanized shortly before the natural death of the affected sibling,
typically at 3.5-4 weeks of age and either used for skeletal analysis or for brain
antibody staining. These animals were progeny from the first experiment
(Chapter 2).
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3.3 Skeletal Staining
Animals were euthanized once hydrocephaly was visible and death was
imminent, typically between 3.5 and 4 weeks of age. They were immediately
skinned, eviscerated and placed in a 95ºC water bath for 90 seconds to loosen
fat and muscle, which was then peeled off the bones. The skeletal specimens
were fixed overnight in 4% paraformaldehyde (Fisher Scientific) at 4ºC, briefly
rinsed with deionized water and placed in acetone (Fisher Scientific) overnight.
They were then washed 3 times with deionized water, covered with Alcian Blue
(Acros) solution and placed in total darkness overnight. The next day,
specimens were washed 3 times with 70% ethanol (Florida Distillers, Co.)
changing the solution every 2.5 hours and left overnight in a 1% KOH (Acros)
solution. KOH was removed and Alizarin Red (Ricca Chemical Co.) solution
added to cover specimens and left again in complete darkness overnight.
Specimens were then placed in a 20% glycerol (Fisher Scientific) in 1%KOH for
2 days and then stored in a 1:1 glycerol:ethanol solution. Adapted from Nagy et
al. (2003).
3.4 Brain Dissection
Animals used for brain studies were also euthanized once hydrocephaly
was visible and death was imminent, typically at 3.5 to 4 weeks of age. Animals
were anesthetized and perfused initially with 0.1M PBS, pH 7.4 (Fisher
Scientific) and immediately followed with 4% paraformaldehyde. Animals were
decapitated, the head skinned and the skull chipped away using rongeurs.
Brains were rinsed in PBS, measured and put in 4% paraformaldehyde, gently
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rocking at 4ºC overnight. The following sequence was followed over
subsequent days and solutions were changed when the brains had sunk to the
bottom of the 50ml tube: 10% sucrose; 20% sucrose; 30% sucrose and finally a
1:1 solution of 60% sucrose:Tissue-Tek Freezing Medium (Sakura). Brains
were then embedded in pure Tissue-Tek Freezing Medium and stored at
-80ºC. Later, transverse cryosections of 10µm were taken of the frozen brains
and used for antibody staining.
3.5 Antibody Staining
Selected slides were placed on a slide warmer for 2 hours at 37ºC. Slides
were washed 3 times in PBS pH7.4 for 15 minutes each time. A blocking
solution of 10% goat serum (Fisher Scientific) in PBT (PBS plus 0.1% Tween20; Fisher Scientific) was added in two intervals, once for 15 minutes and then
for 1.25 hours. The primary antibody in 5% goat serum in PBT was added to
slides and left in a humidity chamber overnight at 4ºC: 200µl of Glial fibrillary
acidic protein (GFAP; Sigma) at 1:50. In the morning, the primary antibody
were neutralized using PBS and the secondary antibody (Alexa Fluor 488;
Invitrogen) was diluted 1:100 in 5% goat serum in PBT and left on slides for 2
hours. Slides were washed with PBS and mounted.
4. Results
4.1 Realization of Novel Phenotype
As data was being collected to examine whether or not an interaction exists
between Ednrb and Pax3 in the melanocytic lineage (previously described in
Chapter 2), a number of animals were born that exhibited the same
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developmental anomalies with complete lethality. All pups appeared normal at
birth; at approximately 3 weeks of age a number of the progeny appeared
smaller than their littermates and their heads became unusually dome shaped.
The heads of the affected pups seemed to grow larger as the week went on,
especially in the frontal areas. By 4 weeks of age, all pups were dead except
for one which lived to approximately 8 weeks of age. Some of the affected pups
also appeared to develop kyphotic curvatures of the thoracic spine (Figure 1).
4.2 Sample Size and Demographics
A total of 23 affected pups were among the 428 animals born from the
EdnrbS-l/+ x Pax3Sp/+ cross signifying that 5.4% of all progeny born in the study
developed this lethal phenotype. Of these 23, 3 died prior to the realization that
a trend was emerging and because genotyping is done at 4 weeks of age, no
genetic data is available on these 3 pups other that they were born in the
second generation. The remaining 20 pups were genotyped and examined for
brain and skeletal abnormalities.
Fifteen of the 20 affected pups (75%) evaluated were female. Although the
total was skewed toward female gender, the distribution among genotypes
does not seem to be favored by one gender or the other, at least within this
small sample. Males and females appear in all genotype categories: 8 females
and 2 males were Pax3Sp/+, 4 females and 2 males were EdnrbS-l/+ ::Pax3Sp/+
and 3 females and 1 male were wildtype at these two loci (Table 1). Initially
there appeared to be generational bias (favoring generations 2 and 3) but one
mutant pup was a first generation progeny. Generation 2 produced 11 mutant

113

pups and generation 3, 8 mutant pups. Twenty-two of the 23 mutant animals
died between 3.5 and 4 weeks of age; one mutant mouse, who was not a runt,
did not develop hydrocephaly until the 7th week of life and was dead by the 8th
week. Of interest, several of the affected mice had microphthalmia.
4.3 Skeletal Abnormalities Seen in Mutant Mice
All affected mice developed hydrocephaly and were smaller than their
littermates; the only affected mouse that was not smaller than his littermates
was the one mouse that didn’t develop hydrocephaly until the 7th week of life
and survived until the 8th week. Upon examination of the affected progeny,
several of them had a curvature of the spine equivalent to thoracic kyphosis,
their rib cages appeared wider and their organs were tucked further up into
their rib cages than their unaffected littermates (Figure 2). Note the difference in
head shape between the normal (Figure 2A) and the affected (Figure 2B)
littermates. The abnormal shape of the head is seen again in the affected
(Figure 3A) versus the normal (Figure 3B) littermates. The dorsal view seen in
the bottom of figure 3 exemplifies the difference in size seen between affected
(C) and non-affected (D) mice. The difference in the density and development
of the pelvic area is striking.
4.4 Differences in Brain Morphology
The brains of the affected mice were always larger than the brains of their
normal littermates in all dimensions measured: length, width and depth (Table
2). Often times the skulls of affected mice were soft and the meninges thick.
During dissections, a clear liquid commonly leaked out of brains of affected
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mice and often times during the fixation process these brains would deflate
somewhat. Brains of affected mice often had blood in the skull cavity, the
cortical area of the olfactory nucleus and between the two hemispheres. During
cryosectioning along the coronal plane, blood was often seen in the outer
cortical layer and would diminish as sectioning progressed towards the caudal
aspect of the brain.
The most striking difference between the brains of the affected and
unaffected mice was the size of the ventricles. In particular, the 4th ventricle
was typically huge when comparing the affected brain to the normal brain. An
increase in glial cells and processes was clear when comparing the brains of
the affected mice to the brains of the normal mice (Figure 4).
5. Discussion
Expansion of the cranial cavity from a normal sloping forehead to a domedshaped head during the neonatal period suggested the development of
hydrocephaly, and upon further evaluation, morphological studies supported
this initial hypothesis. Approximately 5% of the progeny born from an EdnrbS-l/+
and Pax3Sp/+ cross developed this abnormal phenotype which resulted in 100%
lethality. Presence of this novel phenotype was more prevalent in second and
third generation progeny but one pup born in the first generation developed
hydrocephaly.
Hydrocephaly literally means water (“hydro”) on the brain (“cephaly”); the
water being cerebrospinal fluid (CSF). Cerebrospinal fluid bathes the brain and
spinal column and then is reabsorbed back into the bloodstream all the while
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serving as a protective cushion, and nutrient supplier and waste removal
system for the brain. A blockage of any type can trap CSF within the confines of
the ventricular system causing pressure on sensitive brain tissue, subsequent
swelling and tissue damage (Rekate, 2009). Reactive gliosis, the generation of
astroglia, is seen as a measure of stress and tissue damage in the central
nervous system (Aoyama et al., 2006; Miller and McAllister, 2007). It has been
estimated that 1 in 500 children are affected with hydrocephaly (National
Institute of Neurological Disorders and Stroke, 2009) and a quick search on
PubMed reveals a plethora of research activity (over 22,000 articles). Yet little
is known about the mechanisms of development or truly adequate treatment of
hydrocephaly.
Hydrocephaly appears to be a complicated, multigenetic

disorder

(Takahashi et al., 2008; Town et al., 2008; Zador et al., 2007) often with the coconcurrence of polycystic kidney disease (Liebau et al., 2007; Town et al.,
2008). Stumpy, a recently characterized highly conserved gene required for
mammalian ciliogenesis, results in complete penetrance of hydrocephalus and
polycystic kidney disease in mice with the homozygous null condition (Town et
al., 2008). Interestingly, several observable development trends seen in my
mice are similar to theirs in that both our mutant pups were born with normally
shaped heads which became domed shaped during the neonatal period and
these pups were smaller than normal littermates yet had larger brains. Two of
their control pups (<1%) manifested the condition which they concluded may
represent spontaneous development of hydrocephaly in C57BL/6J mice. The
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“wildtype” animals in my population that manifested hydrocephaly may have an
allele of a yet unidentified gene that has low causative influence on the
development

of

hydrocephalus.

Perhaps

in

the

presence

of

Pax3

haploinsufficiency, this unidentified gene is modified and there is a dramatic
increase in the expressivity and penetrance of this defect (80% of affected pups
were Pax3 heterozygotes compared to 20% with two normal Pax3 alleles). In
addition, it is possible that a mutation in Pax3 exacerbates the expression of
the phenotype in the presence of a homozygous-null modifier. In other words,
background strains mixed as generations of progeny were born could increase
incidence of this unidentified allele occurring in the homozygous-null state and
perhaps it is under these circumstances that a Pax3 mutation modifies its
expression. This would explain the preponderance of affected mice in
generations 2 and 3 while there was only one affected mouse in generation
one. It would be interesting to investigate whether or not these affected mice
had abnormal renal morphology, and whether or not their expression of Stumpy
is normal.
The skeletal abnormalities seen in some of the affected animals insinuate
that the genetic network underlying this phenotype may be dependent on the
allelic variations present at the locus. In the case of piebald, the varying lengths
of deletions of the piebald gene affected gene expression and dictated whether
the mice displayed hydrocephaly, skeletal defects, cartilage malformations of
the head or a combination of these defects (O'Brien et al., 1996). The possibility
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remains open that the presentation of allelic variance will manifest in similar but
varying phenotypes in our mutant mice as well.
The complexity of elucidating genetic networks is magnified further by the
possibility of subunits of a modifier gene having substantially different effects on
gene expression. In the case of the Reelin signaling pathway, the Pafah1b
Alpha subunits have profoundly different effects on brain development (Assadi
et al., 2008). Appropriate Pafah1b1 association with genes in the Reelin
pathway is necessary for proper layering of the brain and defects in this
interaction results in layering defects and hydrocephaly. Mutations in Pafah1b3
aggravate the layering defects while mutations in Pafah1b2 strongly suppress
the development of hydrocephaly in mutant mice destined to develop this
condition.
Background strains also have tremendous impact on gene penetrance and
expressivity. To establish whether mice of five commonly used inbred
background strains were born with similar ventricular size and volume capacity,
Hino and colleagues (2009) examined ventricles in newborn mice on MRL/Mp,
C57BL/6, C3H/He, DBA/2 and BALB/c background strains. The MRL/Mp strain
had the largest ventricles and the lipid droplets lining the ventricles were fewer
in number and smaller than those present in other backgrounds. The authors
concluded that the initial increased volume of CSF and the decreased number
of lipid molecules (which supply nutrients) may increase the risk of developing
hydrocephaly. Other studies have also shown that the C57BL/6J background
decreases the incidence of hydrocephaly in mice (Takahashi et al., 2008;
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Tapanes-Castillo et al., 2009) just as it decreases the hypopigmentation
phenotype. However, while severity of hypopigmentation decreases on a
C57BL/6J background, the incidence and severity of aganglionosis increases
(Cantrell et al., 2004) implying that background modifiers can exacerbate or
diminish gene expression. It is possible that the incidence of hydrocephaly in
my population is only 5.4% due to the effect of C57BL/6J background modifiers
and that an interaction between Ednrb and Pax3, or a modifier of one or both of
these, is minimized because of the background strain. The Ednrb mice were
originally on an LLE background, and although there have been several years
of generations on a C57BL/6J background, it is possible that a modifier of Pax3
(although dilute) exists in the Ednrb background. And as in the case of Stumpy,
perhaps until that modifier had the opportunity to exist in a homozygous state in
the presence of a Pax3 mutation it went along relatively undetected.
Much work needs to be done in order to characterize the etiology of the
hydrocephaly and skeletal deformities seen here. Determining candidate
genes, single polymorphisms, types of mutations involved and microarray
analysis may begin to illuminate the genetic interaction underlying the
development of hydrocephaly in this particular population.
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Figure 4.1 Normal and affected littermates. (A) Littermates at 4 weeks minus a
day, the mouse on the left appears normal while the mouse on the right is
developing a domed-shaped head and eyes appear smaller than its sibling’s
eyes. (B) is the same affected mouse from panel (A). The body shape is more
hunched and rounder than those of its littermate. Both animals are female.

Pax3Sp/+::EdnrbS-l/+

Pax3Sp/+
F1
F2*
F3
Totals:

Wildtype

♀
♀♀
♀
♀
♀♀
♀
♀
8♀

♂

♀
♀

♂

♀
♀

♂

♀

♂

♀

2♂

4♀

2♂

3♀

♂

1♂

*Three animals died prior to genotyping or recognition of novel phenotype.
Table 4.1 Distribution of affected progeny according to generation, genotype
and gender. Animals are classified by generation according to their genotype
and gender. Of the 20 animals genotyped, 10 were Pax3Sp/+, 4 were
Pax3Sp/+::EdnrbS-l/+ and 4 were wildtype for both these genes. While no gender
pattern emerged via genotype or generation there were a predominance of
females (15 females out of 20 animals). Three animals (F2) died prior to
genotyping or recognition of novel phenotype. F2 = 2nd generation.
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Figure 4.2 Skeletal staining showing curvature of the spine, rib cage expansion
and hydrocephalic head. (A) Normal curvature of the mouse spine in the normal
mouse as compared to (B) kyphotic curve of the thoracic part of the spine seen
in the affected mouse. (C) Rib cage had normal number of ribs but has rounded
and wider when compared to (D) the unaffected littermate. Both specimens are
female, age 4 weeks old. These mice were depicted in Figure 1; the affected
mouse is Pax3Sp/+::EdnrbS-l/+ and the normal littermate is Pax3Sp/+.
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Figure 4.3 Skull and pelvic differences. (A) Affected mouse exhibits misshapen
head secondary to hydrocephaly as compared to (B) unaffected littermate. (C)
Affected mouse is much smaller in overall size and also has considerably less
bone in the pelvic region as compared to (D) its littermate. Specimens are
female, 4 weeks old and Pax3 heterozygotes.
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Normal Brain

Mutant Brain

Length

15cm

17.1cm

Width

10cm

11.5cm

Depth

5cm

6.5cm

Table 4.2 Dimensions of two brains. The brain from the affected mouse is
larger than the brain of its unaffected littermate in all dimensions. All affected
and unaffected brains followed this pattern; this example was chosen as it was
an average example of the difference in one pair of littermate brains. Brains
come from female littermates who were 3.5 weeks old and both were Pax3
heterozygotes.

Figure 4.4 Brain morphology differences. Antibody staining of 4-week old
female murine brains with GFAP shows an increase in glia in the (B) affected
brain when compared to (A) a normal brain. In addition, there are fewer cells in
(D) the brain tissue of the hydrocephalic brain than in (C) the normal brain. CC
= corpus callosum, Magnification: 40X; arrows indicate glia.
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V. Conclusions, Future Directions and Implications
1. Conclusions and Future Directions
Genetic interactions provide a complicated network of signals that modulate
penetrance and expressivity of gene expression. To elucidate some of the most
basic mechanisms of development is to unravel the process of multipotent
progenitor cells determining cell fate and subsequently differentiating into highly
specialized cells. Neural crest cells emerge as a population of multipotent cells
that generate a diverse array of cells and tissues, among them the pigment
cells. Melanogenic genes have been described and major melanogenic
transcription factors identified but the study of the genetic interactions between
the genes that modulate the differentiation of these cells is underway. To that
regard, I have determined that interactions between Sox10 and Ednrb, and
Pax3 and Ednrb do exist.
Mouse pigmentation phenotypes were used as they are an excellent system
in which to elucidate the underpinnings of genetic interactions due to their high
homology with the human genome and their short generation time. In chapter 2,
I showed that progeny harboring double heterozygous mutations in Sox10LacZ
and EdnrbS-l displayed significantly aggravated pigmentation phenotype in
generations two and three of the crosses: in other words, animals who were
double heterozygotes had areas of hypopigmentation significantly larger that
the sum of the hypopigmentation of Sox10LacZ/+ and EdnrbS-l/+ areas. This
suggests that rather than there being an additive effect of the mutations, a
synergistic effect occurred indicating that Sox10 and Ednrb do interact in the
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melanocyte lineage. A similar outcome was seen in the Pax3Sp/+ cross with
EdnrbS-l/+ in which double heterozygote progeny in generations two and three
exhibited significantly larger areas of hypopigmentation than the progeny
harboring only one of the two mutations.
Melanocytes are derived from the NC. Given that NC cells provide
progenitor cells for diverse tissues and organ systems throughout the
vertebrate body, it is of no surprise that when a mutation affects NC
development early on other cells may be compromised as well. In the case of
Sox10 mutations, haploinsufficient mice can also develop aganglionosis or
hearing phenotypes in addition to hypopigmentation. Other studies have shown
an interaction between Sox10 and Ednrb but with varying results. Stanchina
and colleagues (2006) showed aggravated phenotypes (pigmentation and
aganglionosis) when using an Ednrb hypomorph crossed with Sox10Dom or
Sox10LacZ while two other studies showed no effect of double heterozygosity on
pigmentation phenotype (Cantrell et al., 2004; Hakami et al., 2006). Differences
between these results may lie in some yet unidentified background modifier that
is present in higher levels in some of these in-bred strains than in other in-bred
strains. If no genetic interaction existed between Sox10 and Ednrb then all
studies would have produced negative results; in addition, in human
melanocytes two Sox10 binding sites have been identified on Ednrb
(Yokoyama et al., 2006). I do not believe that these mixed results are due to
stochastic events but rather that gene expression and penetrance may be
dependent on modifiers of which we are not yet aware. A clear analysis of
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phenotypic expression and the background in which it is expressed will help
elucidate the myriad of interactions that comprise the signals necessary for the
process of cell fate determination and differentiation. It is this process of
discovery that will enable us to unravel and understand how diseases vary in
their onset and severity.
In chapter 3, I showed that when using a transgene to deliver additional
Ednrb to the melanoblasts of Sox10 deficient animals, the hypopigmentation
phenotype was rescued in all progeny. Sox10 heterozygous mice display a
hypopigmented ventral spot approximately half of the time, yet when crossed
with a transgenic mouse that was created to deliver additional Ednrb to
melanocyte precursors there was a complete rescue of coat color. If Sox10
activates the expression of Ednrb as I suspect it does, then Sox10
heterozygous mice may have a larger belly spot than the Ednrb heterozygous
mice due to the initial effect of Sox10 haploinsufficiency on the premigratory
and early migratory melanoblasts in addition to the insufficient activation of
Ednrb. Sox10 heterozygous mice survive with few, if any side effects, implying
that the level of Sox10 in these mice is still adequate to sustain overall cellular
function. The delivery of additional Ednrb to melanoblasts that have survived
Sox10 haploinsufficiency appears to compensate for the lower level of Ednrb
activation thereby rescuing the pigmentation phenotype. Interestingly, the
transgenic addition of Sox10 to Ednrb heterozygotes did not rescue the
hypopigmentation phenotype (Hakami et al., 2006). The delivery of additional
Sox10 to a system with limited Ednrb provides no additional Ednrb to

130

compensate for heterozygosity. In other words, once the limited amount of
functional Ednrb has been fully activated by Sox10 the addition of more Sox10
does nothing because there is no more Ednrb available to be activated by
Sox10. Conversely, the addition of Ednrb to a Sox10 limited system does what
Sox10 would have normally done – provide sufficient levels of Ednrb signaling
to

promote

proper

melanoblast

dispersal

and

thereby

rescues

the

hypopigmentation phenotype of the Sox10 heterozygous mutant.
Pax3 and Ednrb have a more complicated relationship. Pax3 heterozygous
mice exhibit a completely penetrant hypopigmentation phenotype and the
transgenic delivery of Ednrb produced a partial rescue. Double heterozygous
animals also displayed a significantly larger area of hypopigmentation as
discussed above and in chapter 2. However, the transgene rescued the
hypopigmentation in only 24% of the progeny and in another 10% there was a
partial rescue. The ability of the transgene to rescue the pigmentation
phenotype may differ due to the temporal expression of Sox10 and Pax3.
Sox10 and Ednrb are co-expressed temporally while Pax3 expression is
downregulated at the time when Ednrb is being upregulated. If this is the case,
then Ednrb may be activated too late to rescue melanocyte progenitors in the
Pax3Sp/+. It is also possible that the insult of Pax3 haploinsufficiency is more
devastating to the premigratory melanoblast precursors and that the additional
Ednrb is insufficient to rescue more of the cells.
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In order to establish the timing of the rescue in the Sox10 heterozygous
mice, Sox10LacZ/+ embryos with and without the transgene were evaluated at
E11.5 (the age at which melanoblasts have first populated the entire length of
the embryo). In situ hybridization using a Pmel17 riboprobe showed that the
transgenic expression of Ednrb rescued the Sox10 deficient melanoblasts by
E11.5. Pmel17 was used as its expression is not regulated by Sox10 and it is
among the most sensitive of melanoblast markers (Loftus et al., 2009; Valencia
et al., 2006). Once the rescue was established, the mechanism of this rescue
came into question. Cell survival assays in E11.5 and E12.5 embryos indicate
that the rescue is not due to the effect of the transgene on melanoblast survival.
Proliferation and migration studies at E11.5 or earlier will help elucidate the
answer to this question.
During the Pax3Sp/+ and EdnrbS-l/+ study, a novel phenotype in the progeny
became apparent. Approximately 5% of pups born in this experiment developed
hydrocephaly and died by 4 weeks of age. In addition to the hydrocephaly,
some pups also exhibited skeletal abnormalities that included kyphosis of the
thoracic region and smaller pelvic regions that appeared less ossified than the
pelvic regions of their unaffected littermates. All affected pups except one were
much smaller than their littermates. Interesting characteristics of this population
include that 80% of all affected animals were Pax3Sp/+ and 75% were female.
All except one of the affected animals were born in the second or third
generation of the cross.
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All affected progeny developed severe hydrocephaly (which became
apparent in the 4th week of life) from which they died. Brain morphology studies
showed enlarged brains and bilaterally distended 4th ventricles in all animals.
Many of the skulls of these animals were softer than those of their unaffected
littermates. In addition, all affected animals were smaller than their normal
littermates (except one) and skeletal studies confirmed that their skeletons
were indeed smaller than usual. Also of interest was that some of the affected
animals had kyphosis, a curvature of the spine in the thoracic region, and had a
much smaller pelvis than normal littermates.
The founders used to create this Pax3Sp/+::EdnrbS-l/+ population originally
came on different backgrounds and were backcrossed (independently) for
several years prior to being used in this study. The Pax3 mutant mice came on
a C57BL/6J background and the Ednrb mutant mice were originally on an LLE
background and were later transitioned to a C57BL/6J background. We have
many different lines of mice on the C57BL/6J background and on other
backgrounds as well, and we have created double and triple mutants of some
of these lines and have never seen hydrocephaly develop in any of these
progeny. In this study however, it was apparent early on that some unknown
interaction was occurring inducing hydrocephalus and intermittently inducing
skeletal deformities. This was the first time in the history of our lab that the
Pax3Sp/+ animals were crossed with EdnrbS-l/+ animals and this tangential
finding was intriguing. Eighty percent of the affected animals were Pax3
heterozygotes while 20% were not. So the question remains as to what kind of
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modifier lies in the Ednrb background that, when in the presence of Pax3
haploinsufficiency, increases the incidence of hydrocephaly and skeletal
deformities?
The complexity of illuminating genetic cascades and networks is a
monumental task that will undoubtedly take years of research. DNA analyses to
determine candidate genes, single polymorphisms and microarray analyses
could be used to begin to identify potential genes that are being modified by a
mutation in Pax3.
2. Implications
One of the mysteries of medical science is that individuals who harbor the
same mutations can vary tremendously in the course of the disease and in how
much they suffer. Gene expression and penetrance varies according to the
presence or absence of other genes, or to background modifiers that were
previously undetected. The four types of Waardenburg’s syndrome bring to light
some of the difficulties of studying genetic interactions: (1) similarity of signs
and symptoms despite defects in different genes; and, (2) differences in
severity and penetrance of the disease between families as well as within
families. These complexities arise from the myriad of genes involved in every
transaction that occurs along the developmental path. To make matters even
more difficult, genes typically function in a nonlinear fashion and may be
affecting expression of more than one gene at any given time.
It should be of no surprise that genetic networks contain a level of
unprecedented complexity given the intricate and delicate balance of
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developmental pathways, biochemical cycles, immunological responses and
the many other highly sophisticated systems that integrate to become a living
organism. Phenotypic expression is anchored in gene expression and it is a
matter of time and patience until the underlying connections and mechanisms
are uncovered. Elucidation of genetic interactions will help us understand how
the mutated gene is modulated, with the intention of one day being able to
provide gene therapy to individuals in need.
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APPENDIX I.
A. Isolation of DNA from Tail Biopsies
Animal is briefly anesthetized using a few drops of Isoflurane (Abbott).
Working quickly, a numbered ear tag is placed in the right ear and the tip of the
tail is clipped (0.5cm). The tail is briefly cauterized to prevent bleeding. Each tail
is placed in 500µl of tail lysis buffer (100mM Tris-Cl pH 8.0, 5mM EDTA pH 8.0,
200mM NaCl, 0.2% SDS; Fisher Scientific) and 5µl of proteinase K (10mg/ml;
Promega) and placed in a 55-60ºC water bath overnight.
Digested tails were cooled with 167µl 5M NaCl (Fisher Scientific) for 10
minutes. Samples were then centrifuged for 10min at 4ºC; supernatant
transferred to clean microcentrifuge tubes and 1 volume of cold 100% EtOH
(Florida Distillers Co.) added. Solution was shaken vigorously (DNA strands
became visible) and centrifuged for 10min at 4ºC. Supernatant was poured off
and the remaining pellet was dissolved in 1X TE (100mM Tris-Cl pH 8.0,
10mM EDTA pH 8.0; Fisher Scientific) (Miller et al., 1988).
B. Genotyping of Mouse Mutants
DNA extracted from tails was used to genotype mice. Individual PCR
reactions (10µl total volume/reaction) were set up for each of the genes being
tested.
PCR reaction for Ednrb consisted of 1µM of each primer (Ednrbf: 5’AATGTATGGGCATGTGCGTG-3’;
and
Ednrbr:
5’GAGATAGTCAACCAAAACAA-3’; Invitrogen), 1X buffer, 1.5mM MgCl, 1 unit of
Taq (Promega), 2.5mM of each of the four deoxynucleotides (dNTPs;
Invitrogen). Reactions were cycled 30 times at 94ºC for 30s, 58ºC for 30s and
72ºC for 30s. Amplified DNA was visualized on a 15% polyacrylamide gel made
from 30% acrylamide/bis-acrylamide with 10% of 5X TBE, 1% ammonium
persulfate (Fisher Scientific) and 0.1% TEMED (Sigma). All gels were run at
350volts for 3.5 hours at 4ºC. Ethidium bromide (Fisher Biotech) was used to
visualize DNA.
To genotype Pax3Sp mice, the point mutation was amplified with primers:
P3in3F
(5’-GAGAGGGTTGAGTACGTTAGCTGG-3’)
and
P3ex4
(5’CTCGCTCACTCAGGATGCC-3’; Invitrogen). The reaction protocol and
thermocycler program are identical to that of Ednrb (listed above). Products are
visualized on a 15% polyacrylamide gel resulting in a single band around 230bp
for a wildtype and a heteroduplex band at this same site for the heterozygote.
Sox10LacZ/+ is a knock-in mutant and requires 3 primers: 5’ Sox10 (5’CAGGTGGGCGTTGGGCTC-3’); 3’ Sox10 (5’-CAGAGCTTGCCTAGTGTCTT3’); and 3’ LacZ (5’-TAAAAATGCGCTCAGGTCAA-3’). In addition to the 1µM of
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each primer (Invitrogen), 1X buffer, 2mM MgCl, 1 unit Taq (Promega), 5%
DMSO (Fisher Scientific), 2.5mM of each dNTP (Invitrogen) and 1µl DNA.
Thermocycler conditions were 94ºC for 30 s, 55ºC for 30 s, and 72ºC for 30 s
for 32 cycles. Products were visualized on a 2% agarose (Fisher Scientific) gel
resulting in a 500bp band for wildtype and a 600bp for the mutated allele.
Animals homozygous for Sox10 are embryonic lethal, typically by E13.5.

Figure A.1 Possible results of gel electrophoresis of mice tail DNA genotyping.
Ednrb genotyping of tail DNA can result in either homozygous (Ednrbs-l/s-l),
heterozygous (Ednrbs-l/+) or wildtype identification of animals. Sox10 and Pax3
genotyping of tail DNA results in either heterozygous (Sox10LacZ/+ or Pax3Sp/+)
or wildtype animals. Both Sox10 and Pax3 null mutants are embryonic lethal by
E13.5-14.5).
C. Buffers
Tris Acetate EDTA (TAE) (typically made as 50X solution)
40mM Tris-acetate
1mM EDTA
(24.2g Tris, 5.7ml Glacial Acetic acid, 10.0ml 0.5M EDTA pH 8.0, bring
volume up to 100ml with dH20 and autoclave.)
Tris Borate EDTA (TBE) (typically made as a 5X solution)
45mM Tris-borate
1mM EDTA
(54g Tris, 27.5g Boric acid, 20ml 0.5M EDTA pH8.0, bring volume up to 1
liter with dH20 and autoclave.)
Tris EDTA (TE) (typically made as a 10X solution)
10mMTris, pH 7.5
1mM EDTA pH8.0
(10ml 1.0M Tris, 2ml 0.5M EDTA pH 8.0, bring volume up to 100ml with
dH20. Adjust pH to 8.0 and autoclave.)
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APPENDIX II.
A. Staging and Harvesting of Embryos
Mice were mated overnight and staged embryos were dated as 0.5d noon
the day the vaginal plug was observed. Embryos were harvested at E11.5 and
E12.5 by euthanizing the pregnant dam via cervical dislocation and dissecting
embryos through a transverse abdominal incision. Embryos were immediately
placed in PBS (the pH of which was determined by the subsequent procedure,
see Appendices II.D and II.H) and yolk sacs were saved for DNA extraction
(Appendix II.B). Those destined for double staining with LysoTracker Red and
LacZ, were immediately started on that protocol (Appendix II.I). Embryos for in
situ hybridization were dehydrated through a methanol (MeOH; Fisher
Scientific) series (25%:75% MeOH:PBS; 50%:50%; 75%:25% MeOH:PBS for
5min each) and stored in 100% MeOH at -20ºC.
B. Isolation of DNA from Tail Biopsies or Embryonic Yolk Sacs
Isolation of DNA from tail biopsies was achieved using the protocol listed in
Appendix I.A. To genotype embryos, yolk sacs were harvested by taking the
innermost of the 3 embryonic membranes surrounding the developing embryo.
This membrane was placed in 250µl of yolk sac buffer (10mM Tris-Cl pH 8.0,
10mM EDTA pH 8.0, 100mM NaCl, 0.5% SDS; Fisher Scientific) plus 10µl of
Proteinase K (10mg/ml; Promega) and placed in a 55-60ºC water bath
overnight.
Digested yolk sacs were cooled with 200µl 5M NaCl (Fisher Scientific)
for 10 minutes. Samples were then centrifuged for 10min at 4ºC; supernatant
transferred to clean microcentrifuge tubes and 1 volume of cold 100% EtOH
(Florida Distillers Co.) added. Solution was shaken vigorously (DNA strands
became visible) and centrifuged for 10min at 4ºC. Supernatant was poured off
and the remaining pellet was dissolved in 1X TE (100mM Tris-Cl pH 8.0,
10mM EDTA pH 8.0; Fisher Scientific) (adapted from Miller et al., 1988).
C. Genotyping of Mouse Mutants
Sox10, Pax3 and Ednrb mutant animals were genotyped as described in the
materials and methods section of Chapter 2 and Appendix I.B. Sox10LacZ/LacZ
are embryonic lethal at approximately E13.5, hence Sox10 embryos were
harvested at E11.5 and E12.5 enabling the possibility of examining
developmental changes in the Sox10 homozygous condition. DNA amplification
of embryos homozygous for Sox10 generates a 600bp band while wildtype
embryos generate a 500bp band; heterozygous embryos produce both bands.
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Dct-Ednrb transgenic animals were generated in our laboratory (Avner
Ittah, FIU dissertation 2005). The full length Ednrb cDNA (1958bp, genbank
accession # U32329) obtained from pmET-B (Hosoda et al., 1994) was inserted
into the vector pmDct that contains 3431 bp of the mouse Dct promoter and the
BGH poly adenylation signal (Hornyak et al., 2000). Dct-Ednrb transgenic mice
were generated by microinjection of the transgene into FVB F1 zygotes. The
studies presented here were carried out with a line that initially had 150 copies
of the transgene. This line was crossed for over 10 generations with C57BL/6J
mice from our colony. Mice were genotyped using 1µM of each primer DctEdnrbf (5’-ACAAGGAAGACTGGCGAGAA-3’); and, Dct-Ednrbr
(5’TCCTCCCCCTTGCTGTCCTGC-3’; Invitrogen), 1X buffer, 2mM MgCl, 1 unit
Taq (Bioline), 5% DMSO (Fisher Scientific), 2.5mM of each dNTP (Invitrogen)
and 1µl DNA. The amplified DNA was visualized on a 1% agarose gel resulting
in a 2217bp band (Appendix I).The PCRs were performed for 35 cycles under
the following conditions: 94C for 30 s, 57C for 30 s, and 72C for 2 min.

2217bp

600bp
500bp

Figure A.2 Possible results of gel electrophoresis of mice tail or yolk sac DNA
genotyping. Dct-Ednrb results either in a positive 2217bp band indicating
presence of the transgene, or no band at this level indicating that the transgene
was not transmitted. Other bands are non-specific. Sox10 gel shows a 600bp
band for Sox10LacZ/LacZ (-/-), 600bp and 500bp bands for Sox10LacZ/+ (+/-) and a
500bp band for the wildtype (+/+).
D. In Situ Hybridization of Mouse Embryos
In situ hybridization took 4 days to complete. Day 1 (pretreatment and
hybridization): Embryos were rehydrated via a MeOH series using PBT* (PBS**
plus 0.1% Tween-20 Fisher Scientific) 5min for each of the following steps:
75%:25% MeOH:PBT; 50%50%; 25%:75% MeOH:PBT and two washes in
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100% PBT. Embryos were then bleached in 6% H2O2 (Fisher Scientific) in PBT
for 1hr at RT and then permeabilized using 10µg/ml proteinase K (Promega) in
PBT (15min for E11.5 and 18min for E12.5). To neutralize this reaction, 2mg/ml
glycine (Fisher Scientific) in PBT was added for 10min at RT and then washed
twice with PBT. Embryos were postfixed with 4% paraformaldehyde (Fisher
Scientific), 0.2% gluteraldehyde (Sigma) in PBT for 20min. Pre-hybridization
was accomplished by adding 1ml hybridization solution (50% formamide,
5xSSC pH4.5 1% SDS, Fisher Scientific; 50µg/ml yeast tRNA, Sigma; 50µg/ml
heparin, Sigma) and incubated in a 70ºC water bath for 1hr. The prehybridization solution was removed and fresh hybridization solution containing
2µl pMel17 riboprobe per ml of hybridization solution added and left overnight
in the 70ºC water bath.
Day 2 (washing and antibody addition): Embryos briefly rinsed in solution 1
(50% formamide, 5xSSC and 1%SDS; Fisher Scientific) and then washed 3
times more with solution1 (30min each time in a 70ºC water bath). Washing
was continued, 3 more times, using solution 2 (50% formamide and 2xSSC;
Fisher Scientific) and placed in a 65ºC water bath for 30min each time, followed
by washing with TBS plus 0.1% Tween-20 (TBST) 3 times for 5min each time.
Blocking of embryos in 10% goat serum (Fisher Scientific) in TBST for 2hrs,
rocking at RT, during which time the preabsorb anti-digoxigenin antibody was
prepared by adding a pinch of embryo powder to microcentrifuge tubes
containing 0.5ml TBST (1 microcentrifuge tube/embryo) and placed in 70ºC
water bath for 30min. Microcentrifuge tubes were removed from water bath,
vortexed and cooled prior to the addition of 5µl of 100% goat serum and 1µl
anti-digoxigenin antibody (Roche) and rocked at 4ºC for 1hr. After centrifuging
for 5min, the supernatant was collected and 1.5ml of 1% goat serum in TBST
per microcentrifuge tube was added. When embryos were ready, the blocking
solution was removed, the antibody solution added and embryos were left
rocking overnight at 4ºC.
Day 3 (washing the antibody): Embryos were briefly rinsed in TBST and
then washed 4 times in TBST for 1hr each time at RT. Levamisole (2mM;
Sigma) was added to a 5th TBST wash and left overnight, rocking at 4ºC.
Day 4 (detection): Embryos were washed in NTMT (100mM NaCl, 100mM
Tris pH9.5, 50mM MgCl2, 0.1% Tween-20; Fisher Scientific; 2mM levamisole;
Sigma) 3 times for 10min each time. While protecting from light, 45µl 4-Nitro
blue tetrazolium chloride (NBT; Roche) and 35µl 5-Bromo-4-chloro-3-indolylphosphate (BCIP; Roche) were added to 10ml NTMT and added to each
embryo. Still protected from light, embryos were monitored every 30min to
control the level of antibody development (Wilkinson 1998).
*All water used for solutions was Diethylpyrocarbonate (DePC; Sigma) treated
water and therefore RNase-free.
***All PBS used in this protocol was 0.05M, pH7.4.
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E. Pmel17 Template and Riboprobe Preparation
Bacterial Transformation: 2.5µl of Pmel17 plasmid was added to 50µl of
DH5α competent Escherichia coli and incubated on ice for 30min, heat shocked
for 20sec at 37ºC and then immediately placed in ice for 1min. 950µl Luria
Broth (LB) was added and mixture was incubated for 1hr at 37ºC (30min into
the hour 30µl Ampicillin was added). An LB plate containing Ampicillin was
inoculated and left to incubate overnight at 37ºC.
Glycerol Stock of Pmel17 Plasmid: Inoculated 5ml LB with isolated colonies
from LB plate and incubated overnight at 37ºC shaking at 250rpm. 750µl of
freshly grown transformed bacteria was added to 750µl sterile glycerol stock
and stored at -80ºC.
DNA Isolation and Purification: 5ml LB was inoculated with glycerol stock of
Pmel17 plasmid (stored in -80ºC) and incubated overnight at 37ºC at 250rpm.
Wizard Plus SV Mini Prep: DNA Purification System (Promega catalog #A1460)
was used for the following steps. 2ml of fresh culture was centrifuged and pellet
was resuspended in 250µl Resuspension Solution. To this, 250µl Cell Lysis
Solution was added, inverted 4 times followed by the addition of10µl Alkaline
Protease Solution and again inverted 4 times to mix gently, then incubated at
room temperature for 5min. 350µl Neutralization Solution was added,
centrifuged for 10min and the clear lysate was decanted into the spin column
and centrifuged again for 1min. Flowthrough was discarded and 750µl Wash
Solution added, centrifuged for 1min, 250µl Wash Solution, centrifuged for 2min
and transferred to spin column to remove Wash Solution. Finally, 50µl of
nuclease free H2O was added and stored at -20ºC.
Template Preparation: 10µl of Pmel17 plasmid was digested with 2µl of
the restriction enzyme KPN1 (Promega), 2µl buffer J and 6µl UVH2O at 37ºC
for 2hrs. Linearized template was then cleaned via phenol-chloroform (Fisher
Scientific) extraction and ethanol (Florida Distillers Co.) precipitation and
resuspended in H2O to a concentration of approximately 1µg/µl.
Riboprobe Synthesis: 5µl template was added to 4µl 5x transcription
buffer (Roche), 2µl nucleotide tri-phosphate (NTP) labeling mix (Roche), 2µl T3
polymerase (Promega), 1µl RNase inhibitor (Promega) and 6µl DePC H2O and
incubated at 37ºC for 2hrs. At this point, 2µl 0.2M EDTA, 2.5µl 4M LiCl and
75µl EtOH were added to precipitate riboprobe; pellet was then washed in 70%
EtOH, resuspended in 22.5µl DePC H2O, 2.5µl 4M LiCl and 75µl EtOH to
precipitate again and a final wash in 70% EtOH. This pellet was dissolved in
20µl DePC H2O and 80µl hybridization solution and stored at -20ºC.
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F. Embryo Powder
12.5-14.5 day old embryos were homogenized in cold PBS pH7.4. Four
volumes of acetone were added and mixture was incubated on ice for 30min,
then centrifuged for 10min at 4ºC. Supernatant was discarded, the pellet
washed again in cold acetone and spun down for another 10min. Supernatant
was again discarded and pellet was macerated into a fine powder and air-dried.
Embryo powder was stored at 4ºC.
G. Cell Counts of Pmel17 labeled Melanoblasts
Cells labeled with Pmel17 that were located in the torso from the fore limb to
the hind limb were counted from a picture taken of the area at 3.2x
magnification. The angle of lines drawn to define the area, lighting and
magnification were kept constant for all pictures taken.

Figure A.3 Defining the area for cell counts of Pmel17 positive cells. Lines
were drawn that intersect the posterior most aspect of the forelimb and the
anterior most aspect of the hindlimb. E11.5 Sox10 heterozygote.
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H. Lysotracker Red and LacZ Double Staining of Mouse Embryos
Embryos were dissected and rinsed in cold 0.05M PBS* and placed in 5µM
LysoTracker Red DND-99** (Invitrogen) at 37ºC for 30min. Embryos were
washed twice in PBS, 2% paraformaldehyde (PF; Fisher Scientific) for 1hr at
room temperature (RT), washed twice more with PBS and then left overnight at
30ºC in LacZ solution (5µM ferricyannide, 5µM ferrocyannide, 2mM MgCl2,
0.01% sodium deoxycholate (Fisher Scientific), 0.02% nonidate p-40 (Roche)
and 1mg/ml X-gal (Invitrogen). Rinsed twice in PBS to stop reaction and a 10%
sucrose (Fisher Scientific) solution was added to embryos for overnight
incubation at 4ºC, rocking gently. Finally, embryos were placed in 20% sucrose
solution for 4-6hrs and embedded in Tissue-Tek Tissue Freezing Medium
(Sakura). Embryos were stored at -80ºC.
*All PBS used in this protocol was pH7.2.
**From this point on, all embryos and solutions were protected from light at all
times.
I. Counts of Lysotracker Red and LacZ+ Cells
Transverse cryosections of 10µm were taken of embryos from the brachial
nerves to the sciatic nerve. Every third section was kept in E11.5 embryos while
every 4th section was kept in E12.5 embryos. Of these sections, 30 equally
spaced sections (e.g. every other section) were selected for counting. Cells that
were blue (LacZ+), elongated and appeared to be traveling along the
dorsolateral pathway were counted and checked for double labeling with
Lysotracker Red.
J. Buffers and Solutions
DePC H2O
0.1%DePC in 1liter dH2O mixed for a minimum of 2hrs on the stir plate in the
hood with an open top; autoclaved and left venting in hood with loose cap.
Glycerol Stock
100% glycerol was added in equal volumes to dH2O and autoclaved.
Luria Broth (done in hood)
1% Tryptone powder
0.5% Yeast Extract powder
1% NaCl
Brought up to 100ml with dH2O, calibrated to pH 7.0, autoclaved, cooled and
added 50µl of 100µg/ml Ampicillin. Stored at 4ºC.
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Luria Broth Agar Plates (done in hood)
10g Tryptone powder
5g Yeast Extract
10g NaCl
15g Agar
Brought up to 1liter with dH2O, autoclaved, cooled slightly to add 250µl of
100µg/ml Ampicillin and poured plates. Once set, stored at 4ºC.
Phosphate Buffered Saline (PBS) (typically made in a 10X solution)
For pH7.4:
11.2ml of 1M Potassium Phosphate Monobasic (KH2PO4)
38.8ml of 1M Potassium Phosphate Dibasic (K2HPO4)
Brought up to 100ml with dH2O and autoclaved
For pH7.2:
16.8ml of 1M Potassium Phosphate Monobasic (KH2PO4)
34.2ml of 1M Potassium Phosphate Dibasic (K2HPO4)
Brought up to 100ml with dH2O and autoclaved
Phosphate Buffer Saline with 0.1% Tween-20 (PBT; made fresh)
1µl of 100% Tween-20 added for each ml of PBS
Tris Buffered Saline with 0.1% Tween-20 (TBST; made fresh)
1µl of 100% Tween-20 added for each ml of TBS
SSC
20xSSC: 175.3gNaCl and 88.2g NaCitrate, volume brought up to 1liter; pH
adjusted to 7.0.
10xSSC, pH4.5: 250ml 20xSSC + 30ml citric acid + 220ml DePC H2O
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